false --12-31 Q1 0001375793 0001375793 2024-01-01 2024-03-31 0001375793 2024-06-26 0001375793 2024-03-31 0001375793 2023-12-31 0001375793 us-gaap:RelatedPartyMember 2024-03-31 0001375793 us-gaap:RelatedPartyMember 2023-12-31 0001375793 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001375793 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2024-03-31 0001375793 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesCPreferredStockMember 2024-03-31 0001375793 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesDPreferredStockMember 2024-03-31 0001375793 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001375793 us-gaap:ProductMember 2024-01-01 2024-03-31 0001375793 us-gaap:ProductMember 2023-01-01 2023-03-31 0001375793 us-gaap:ServiceMember 2024-01-01 2024-03-31 0001375793 us-gaap:ServiceMember 2023-01-01 2023-03-31 0001375793 MLRT:LicensingIncomeMember 2024-01-01 2024-03-31 0001375793 MLRT:LicensingIncomeMember 2023-01-01 2023-03-31 0001375793 2023-01-01 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-12-31 0001375793 us-gaap:CommonStockMember 2023-12-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001375793 us-gaap:RetainedEarningsMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2022-12-31 0001375793 us-gaap:CommonStockMember 2022-12-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001375793 us-gaap:RetainedEarningsMember 2022-12-31 0001375793 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-03-31 0001375793 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001375793 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-03-31 0001375793 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001375793 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-03-31 0001375793 us-gaap:CommonStockMember 2024-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001375793 us-gaap:RetainedEarningsMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-03-31 0001375793 us-gaap:CommonStockMember 2023-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001375793 us-gaap:RetainedEarningsMember 2023-03-31 0001375793 2023-03-31 0001375793 MLRT:GlobalTrekXplorationIncAndLevelTwoSecurityProductsIncMember 2024-03-31 0001375793 MLRT:IPAndConsultingIncomeMember 2024-01-01 2024-03-31 0001375793 MLRT:IPAndConsultingIncomeMember 2023-01-01 2023-03-31 0001375793 MLRT:B2BMember 2024-01-01 2024-03-31 0001375793 MLRT:B2BMember 2023-01-01 2023-03-31 0001375793 MLRT:B2CMember 2024-01-01 2024-03-31 0001375793 MLRT:B2CMember 2023-01-01 2023-03-31 0001375793 MLRT:MilitaryMember 2024-01-01 2024-03-31 0001375793 MLRT:MilitaryMember 2023-01-01 2023-03-31 0001375793 MLRT:IPMember 2024-01-01 2024-03-31 0001375793 MLRT:IPMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-03-31 0001375793 MLRT:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-03-31 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-03-31 0001375793 MLRT:GlobalTrekXplorationMember 2024-01-01 2024-03-31 0001375793 MLRT:GlobalTrekXplorationMember 2024-03-31 0001375793 MLRT:GlobalTrekXplorationMember 2023-12-31 0001375793 MLRT:LevelTwoSecurityProductsIncMember 2024-01-01 2024-03-31 0001375793 MLRT:LevelTwoSecurityProductsIncMember 2024-03-31 0001375793 MLRT:LevelTwoSecurityProductsIncMember 2023-12-31 0001375793 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001375793 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001375793 MLRT:PreferredBSharesMember 2024-01-01 2024-03-31 0001375793 MLRT:PreferredBSharesMember 2023-01-01 2023-03-31 0001375793 MLRT:PreferredCSharesMember 2024-01-01 2024-03-31 0001375793 MLRT:PreferredCSharesMember 2023-01-01 2023-03-31 0001375793 MLRT:PreferredDSharesMember 2024-01-01 2024-03-31 0001375793 MLRT:PreferredDSharesMember 2023-01-01 2023-03-31 0001375793 MLRT:ConversionSharesUponConversionOfNotesMember 2024-01-01 2024-03-31 0001375793 MLRT:ConversionSharesUponConversionOfNotesMember 2023-01-01 2023-03-31 0001375793 MLRT:InventergyGlobalIncMember 2022-12-31 0001375793 MLRT:InventergyGlobalIncMember 2024-03-31 0001375793 MLRT:InpixonMember 2019-06-01 2019-06-30 0001375793 MLRT:InpixonMember 2019-01-01 2019-12-31 0001375793 MLRT:InpixonMember 2019-12-31 0001375793 MLRT:InpixonMember 2020-01-01 2020-03-31 0001375793 MLRT:InpixonMember 2021-01-01 2021-12-31 0001375793 MLRT:InpixonMember 2021-12-31 0001375793 MLRT:InpixonMember 2022-12-31 0001375793 MLRT:InpixonMember 2022-01-01 2022-12-31 0001375793 MLRT:InpixonMember 2024-03-31 0001375793 MLRT:SoftwareMember 2024-03-31 0001375793 MLRT:SoftwareMember 2023-12-31 0001375793 MLRT:WebsiteDevelopmentMember 2024-03-31 0001375793 MLRT:WebsiteDevelopmentMember 2023-12-31 0001375793 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001375793 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001375793 us-gaap:EquipmentMember 2024-03-31 0001375793 us-gaap:EquipmentMember 2023-12-31 0001375793 us-gaap:TrademarksMember 2024-03-31 0001375793 us-gaap:TrademarksMember 2023-12-31 0001375793 MLRT:ToolingAndMoldsMember 2024-03-31 0001375793 MLRT:ToolingAndMoldsMember 2023-12-31 0001375793 MLRT:PatentsAndTrademarksMember 2024-03-31 0001375793 MLRT:PatentsAndTrademarksMember 2023-12-31 0001375793 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001375793 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-03-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2022-12-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2022-01-01 2022-12-31 0001375793 2022-04-14 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2019-09-30 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2019-09-01 2019-09-30 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2024-03-31 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2024-01-01 2024-03-31 0001375793 MLRT:UnionBankMember 2024-01-01 2024-03-31 0001375793 MLRT:UnionBankMember 2024-03-31 0001375793 MLRT:UnionBankMember 2023-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2018-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember MLRT:ThreeBorrowingMember 2018-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember MLRT:TwoBorrowingMember 2019-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2019-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2020-01-01 2020-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2020-12-31 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2021-01-01 2021-12-31 0001375793 MLRT:LineofCreditAgreementMember 2021-12-31 0001375793 us-gaap:LineOfCreditMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001375793 us-gaap:InvestorMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2024-01-01 2024-03-31 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2024-03-31 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2024-03-31 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2024-03-31 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2024-01-01 2024-03-31 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2024-01-01 2024-03-31 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-01-01 2023-12-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-03-14 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderMember 2023-09-30 2023-09-30 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember srt:ScenarioForecastMember 2024-09-30 0001375793 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderOneMember 2023-06-09 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MinimumMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MaximumMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderTwoMember 2023-07-25 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderTwoMember 2023-08-30 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderTwoMember 2023-07-25 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderTwoMember 2023-08-30 0001375793 MLRT:ConvertiblePromissoryNotesMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MinimumMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MaximumMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember 2023-01-01 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:LevelTwoSecurityProductsIncMember 2023-01-01 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:LevelTwoSecurityProductsIncMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionPastDueMember 2024-03-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionPastDueMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionMember 2024-03-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionAndOIDMember 2024-03-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionAndOIDMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithVariableConversionMember 2024-03-31 0001375793 MLRT:ConvertibleNotesWithVariableConversionMember 2023-12-31 0001375793 MLRT:NotesIssuedInRelationToAcquisitionWithFixedConversionMember 2024-03-31 0001375793 MLRT:NotesIssuedInRelationToAcquisitionWithFixedConversionMember 2023-12-31 0001375793 MLRT:SBALoanAgreementMember MLRT:EIDLLoanMember 2020-06-10 0001375793 MLRT:SBALoanAgreementMember MLRT:EIDLLoanMember 2020-06-09 2020-06-10 0001375793 MLRT:EIDLLoanMember 2024-01-01 2024-03-31 0001375793 MLRT:EIDLLoanMember 2024-03-31 0001375793 MLRT:RelatedPartiesMember 2024-01-01 2024-03-31 0001375793 MLRT:RelatedPartiesMember 2023-01-01 2023-12-31 0001375793 MLRT:ThirdPartyMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember 2024-03-31 0001375793 MLRT:OfficerLoansMember 2022-11-18 2022-11-18 0001375793 MLRT:OfficerLoansMember 2023-01-01 2023-12-31 0001375793 MLRT:OfficerLoansMember 2023-12-31 0001375793 MLRT:SecondOfficerLoanedMember 2023-01-01 2023-12-31 0001375793 MLRT:SecondOfficerLoanedMember 2024-03-31 0001375793 2020-12-31 0001375793 us-gaap:PreferredStockMember 2024-03-31 0001375793 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001375793 us-gaap:SeriesAPreferredStockMember MLRT:OfficersAndBoardMembersMember 2018-01-01 2018-12-31 0001375793 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-12-31 0001375793 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2019-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-12-31 0001375793 us-gaap:WarrantMember MLRT:AccreditedInvestorMember 2019-01-01 2019-12-31 0001375793 MLRT:AccreditedInvestorMember 2019-01-01 2019-12-31 0001375793 us-gaap:SeriesBPreferredStockMember MLRT:AccreditedInvestorMember 2020-01-01 2020-12-31 0001375793 us-gaap:WarrantMember MLRT:AccreditedInvestorMember 2020-01-01 2020-12-31 0001375793 MLRT:AccreditedInvestorMember 2020-01-01 2020-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2020-12-31 0001375793 us-gaap:SeriesBPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2021-01-01 2021-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001375793 us-gaap:SeriesCPreferredStockMember 2020-12-31 0001375793 us-gaap:SeriesCPreferredStockMember MLRT:AccreditedInvestorMember 2020-01-01 2020-12-31 0001375793 us-gaap:WarrantMember MLRT:AccreditedInvestorMember us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-12-31 0001375793 us-gaap:SeriesCPreferredStockMember MLRT:AccreditedInvestorMember 2021-01-01 2021-12-31 0001375793 us-gaap:WarrantMember MLRT:AccreditedInvestorMember 2021-01-01 2021-12-31 0001375793 MLRT:AccreditedInvestorMember 2021-01-01 2021-12-31 0001375793 MLRT:AccreditedInvestorMember 2021-12-31 0001375793 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001375793 us-gaap:SeriesCPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2021-01-01 2021-12-31 0001375793 us-gaap:SeriesCPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2021-12-31 0001375793 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001375793 us-gaap:SeriesDPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2023-01-01 2023-12-31 0001375793 MLRT:AccreditedInvestorMember 2023-01-01 2023-12-31 0001375793 us-gaap:SeriesDPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2024-01-01 2024-03-31 0001375793 MLRT:AccreditedInvestorMember 2024-01-01 2024-03-31 0001375793 MLRT:TwoThousandEightEquityCompensationPlanMember 2023-03-31 0001375793 MLRT:TwoThousandEightEquityCompensationPlanMember 2024-03-31 0001375793 srt:MinimumMember 2023-12-31 0001375793 srt:MaximumMember 2023-12-31 0001375793 srt:MinimumMember 2024-03-31 0001375793 srt:MaximumMember 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeOneMember 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeOneMember 2024-01-01 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeTwoMember 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeTwoMember 2024-01-01 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeThreeMember 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeThreeMember 2024-01-01 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeFourMember 2024-03-31 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeFourMember 2024-01-01 2024-03-31 0001375793 MLRT:BoardOfDirectorsMember srt:MinimumMember 2024-03-31 0001375793 MLRT:BoardOfDirectorsMember srt:MaximumMember 2024-03-31 0001375793 us-gaap:SubsequentEventMember us-gaap:RelatedPartyMember 2024-06-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure MLRT:Segment MLRT:Integer

false --12-31 Q2 0001375793 0001375793 2024-01-01 2024-06-30 0001375793 2024-08-19 0001375793 2024-06-30 0001375793 2023-12-31 0001375793 us-gaap:NonrelatedPartyMember 2024-06-30 0001375793 us-gaap:NonrelatedPartyMember 2023-12-31 0001375793 us-gaap:RelatedPartyMember 2024-06-30 0001375793 us-gaap:RelatedPartyMember 2023-12-31 0001375793 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001375793 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001375793 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesCPreferredStockMember 2024-06-30 0001375793 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001375793 us-gaap:SeriesDPreferredStockMember 2024-06-30 0001375793 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001375793 us-gaap:ProductMember 2024-04-01 2024-06-30 0001375793 us-gaap:ProductMember 2023-04-01 2023-06-30 0001375793 us-gaap:ProductMember 2024-01-01 2024-06-30 0001375793 us-gaap:ProductMember 2023-01-01 2023-06-30 0001375793 us-gaap:ServiceMember 2024-04-01 2024-06-30 0001375793 us-gaap:ServiceMember 2023-04-01 2023-06-30 0001375793 us-gaap:ServiceMember 2024-01-01 2024-06-30 0001375793 us-gaap:ServiceMember 2023-01-01 2023-06-30 0001375793 2024-04-01 2024-06-30 0001375793 2023-04-01 2023-06-30 0001375793 2023-01-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-03-31 0001375793 us-gaap:CommonStockMember 2024-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001375793 us-gaap:RetainedEarningsMember 2024-03-31 0001375793 2024-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-03-31 0001375793 us-gaap:CommonStockMember 2023-03-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001375793 us-gaap:RetainedEarningsMember 2023-03-31 0001375793 2023-03-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-12-31 0001375793 us-gaap:CommonStockMember 2023-12-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001375793 us-gaap:RetainedEarningsMember 2023-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2022-12-31 0001375793 us-gaap:CommonStockMember 2022-12-31 0001375793 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001375793 us-gaap:RetainedEarningsMember 2022-12-31 0001375793 2022-12-31 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-04-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-04-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-04-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-04-01 2024-06-30 0001375793 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001375793 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-04-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-04-01 2023-06-30 0001375793 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001375793 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001375793 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001375793 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2024-06-30 0001375793 us-gaap:CommonStockMember 2024-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001375793 us-gaap:RetainedEarningsMember 2024-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-06-30 0001375793 us-gaap:PreferredStockMember us-gaap:SeriesDPreferredStockMember 2023-06-30 0001375793 us-gaap:CommonStockMember 2023-06-30 0001375793 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001375793 us-gaap:RetainedEarningsMember 2023-06-30 0001375793 2023-06-30 0001375793 MLRT:GlobalTrekXplorationIncAndLevelTwoSecurityProductsIncMember 2024-06-30 0001375793 MLRT:B2BMember 2024-01-01 2024-06-30 0001375793 MLRT:B2BMember 2023-01-01 2023-06-30 0001375793 MLRT:B2CMember 2024-01-01 2024-06-30 0001375793 MLRT:B2CMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-06-30 0001375793 MLRT:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001375793 MLRT:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001375793 2020-12-31 0001375793 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001375793 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001375793 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-06-30 0001375793 us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-06-30 0001375793 us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-06-30 0001375793 MLRT:ConversionSharesUponConversionOfNotesMember 2024-01-01 2024-06-30 0001375793 MLRT:ConversionSharesUponConversionOfNotesMember 2023-01-01 2023-06-30 0001375793 MLRT:SoftwareMember 2024-06-30 0001375793 MLRT:SoftwareMember 2023-12-31 0001375793 MLRT:WebsiteDevelopmentMember 2024-06-30 0001375793 MLRT:WebsiteDevelopmentMember 2023-12-31 0001375793 us-gaap:SoftwareDevelopmentMember 2024-06-30 0001375793 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001375793 us-gaap:EquipmentMember 2024-06-30 0001375793 us-gaap:EquipmentMember 2023-12-31 0001375793 us-gaap:TrademarksMember 2024-06-30 0001375793 us-gaap:TrademarksMember 2023-12-31 0001375793 us-gaap:ToolsDiesAndMoldsMember 2024-06-30 0001375793 us-gaap:ToolsDiesAndMoldsMember 2023-12-31 0001375793 us-gaap:IntellectualPropertyMember 2024-06-30 0001375793 us-gaap:IntellectualPropertyMember 2023-12-31 0001375793 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-06-30 0001375793 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-06-30 0001375793 us-gaap:TradeNamesMember 2024-01-01 2024-06-30 0001375793 us-gaap:TradeNamesMember 2023-01-01 2023-06-30 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2022-12-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2022-01-01 2022-12-31 0001375793 2022-04-14 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2019-09-30 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2019-09-01 2019-09-30 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2024-06-30 0001375793 MLRT:AssetPurchaseAgreementMember MLRT:ThirdPartyMember 2024-01-01 2024-06-30 0001375793 MLRT:LineofCreditAgreementMember MLRT:AccreditedInvestorMember 2018-12-31 0001375793 us-gaap:LineOfCreditMember us-gaap:InvestorMember 2024-01-01 2024-06-30 0001375793 us-gaap:LineOfCreditMember us-gaap:InvestorMember 2024-06-30 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2024-01-01 2024-06-30 0001375793 MLRT:UnionBankMember 2024-01-01 2024-06-30 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2024-06-30 0001375793 MLRT:UnionBankMember us-gaap:LineOfCreditMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2024-06-30 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2024-06-30 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2024-01-01 2024-06-30 0001375793 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2024-01-01 2024-06-30 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-01-01 2023-12-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:ThirdPartyMember 2023-03-14 2023-03-14 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderMember 2024-01-31 2024-01-31 0001375793 MLRT:UnsecuredTermLoanAgreementMember MLRT:ThirdPartyMember srt:ScenarioForecastMember 2024-09-30 0001375793 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderOneMember 2023-06-09 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MinimumMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MaximumMember MLRT:NoteHolderOneMember 2023-09-20 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderTwoMember 2023-08-30 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderTwoMember 2023-08-30 0001375793 us-gaap:ConvertibleNotesPayableMember MLRT:NoteHolderTwoMember 2024-06-08 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:NoteHolderTwoMember 2024-06-08 0001375793 MLRT:ConvertiblePromissoryNotesMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MinimumMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember srt:MaximumMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember 2023-01-01 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:LevelTwoSecurityProductsIncMember 2023-01-01 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember MLRT:LevelTwoSecurityProductsIncMember 2023-12-31 0001375793 us-gaap:ConvertibleNotesPayableMember 2024-06-30 0001375793 MLRT:ConvertibleNotesWithFixedConversionPastDueMember 2024-06-30 0001375793 MLRT:ConvertibleNotesWithFixedConversionPastDueMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionMember 2024-06-30 0001375793 MLRT:ConvertibleNotesWithFixedConversionMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithFixedConversionAndOIDMember 2024-06-30 0001375793 MLRT:ConvertibleNotesWithFixedConversionAndOIDMember 2023-12-31 0001375793 MLRT:ConvertibleNotesWithVariableConversionMember 2024-06-30 0001375793 MLRT:ConvertibleNotesWithVariableConversionMember 2023-12-31 0001375793 MLRT:NotesIssuedInRelationToAcquisitionWithFixedConversionMember 2024-06-30 0001375793 MLRT:NotesIssuedInRelationToAcquisitionWithFixedConversionMember 2023-12-31 0001375793 MLRT:SBALoanAgreementMember MLRT:EIDLLoanMember 2020-06-10 0001375793 MLRT:RelatedPartiesMember 2024-01-01 2024-06-30 0001375793 MLRT:RelatedPartiesMember 2023-01-01 2023-12-31 0001375793 MLRT:ThirdPartyMember 2023-12-31 0001375793 MLRT:ConvertiblePromissoryNotesMember 2024-03-31 0001375793 MLRT:OfficerLoansMember 2022-11-18 2022-11-18 0001375793 MLRT:OfficerLoansMember 2023-01-01 2023-12-31 0001375793 MLRT:OfficerLoansMember 2023-12-31 0001375793 MLRT:SecondOfficerLoanedMember 2024-01-01 2024-06-30 0001375793 MLRT:OfficerLoansMember 2024-01-01 2024-06-30 0001375793 MLRT:SecondOfficerLoanedMember 2024-06-30 0001375793 us-gaap:PreferredStockMember 2024-06-30 0001375793 us-gaap:SeriesDPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2023-01-01 2023-12-31 0001375793 MLRT:AccreditedInvestorMember 2023-01-01 2023-12-31 0001375793 us-gaap:SeriesDPreferredStockMember MLRT:TwoAccreditedInvestorsMember 2024-01-01 2024-03-31 0001375793 MLRT:AccreditedInvestorMember 2024-01-01 2024-03-31 0001375793 us-gaap:SeriesDPreferredStockMember 2024-03-31 0001375793 us-gaap:InvestorMember 2024-06-30 0001375793 us-gaap:InvestorMember us-gaap:WarrantMember 2024-06-30 0001375793 us-gaap:InvestorMember 2023-06-30 0001375793 us-gaap:InvestorMember us-gaap:WarrantMember 2023-01-01 2023-06-30 0001375793 us-gaap:InvestorMember us-gaap:WarrantMember 2023-06-30 0001375793 us-gaap:WarrantMember 2024-06-30 0001375793 MLRT:TwoThousandEightEquityCompensationPlanMember 2024-06-30 0001375793 srt:MinimumMember 2023-12-31 0001375793 srt:MaximumMember 2023-12-31 0001375793 srt:MinimumMember 2024-01-01 2024-06-30 0001375793 srt:MaximumMember 2024-01-01 2024-06-30 0001375793 srt:MinimumMember 2024-06-30 0001375793 srt:MaximumMember 2024-06-30 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeOneMember 2024-06-30 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeOneMember 2024-01-01 2024-06-30 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeTwoMember 2024-06-30 0001375793 us-gaap:WarrantMember MLRT:ExercisePriceRangeTwoMember 2024-01-01 2024-06-30 0001375793 MLRT:BoardOfDirectorsMember srt:MinimumMember 2024-06-30 0001375793 MLRT:BoardOfDirectorsMember srt:MaximumMember 2024-06-30 0001375793 us-gaap:SubsequentEventMember MLRT:ConsultantMember us-gaap:CommonStockMember 2024-07-29 2024-07-29 0001375793 us-gaap:SubsequentEventMember us-gaap:InvestorMember MLRT:SecuritiesPurchaseAgreementMember MLRT:ConvertiblePromissoryNotesMember 2024-08-02 0001375793 us-gaap:SubsequentEventMember MLRT:SecuritiesPurchaseAgreementMember MLRT:ConvertiblePromissoryNotesMember 2024-08-02 0001375793 us-gaap:SubsequentEventMember MLRT:SecuritiesPurchaseAgreementMember MLRT:ConvertiblePromissoryNotesMember MLRT:FirstTrancheMember 2024-08-06 2024-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares MLRT:Integer MLRT:Segment xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark one)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended ~~March~~June 3130, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number 000-53046

MetAlert, Inc.

(Exact name of registrant as specified in its charter)

Nevada		98-0493446
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

117 W. 9th Street, Suite 1214, Los Angeles, CA, 90015

(Address of principal executive offices) (Zip Code)

(213) 489-3019

(Registrant’s telephone number, including area code)

Securities registered under Section 12(b) of the Act:

Title of each class registered:		Trading Symbol(s)		Name of each exchange on which registered:
Common Stock, Par Value $0.0001		MLRT		None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 3334,~~845~~345,931 common shares issued and outstanding as of ~~June~~August 2619, 2024.

METALERT INC. AND SUBSIDIARIES

For the quarter ended ~~March~~June 3130, 2024

FORM 10-Q

		PAGE NO.
PART I. FINANCIAL INFORMATION
Item 1.	Condensed Financial Statements	3
	Condensed Consolidated Balance Sheets at March 31, 2024 (unaudited) and December 31, 2023 (unaudited)	3
	Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023 (unaudited)	3
	Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (unaudited)	4
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 (unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2024 and 2023 (unaudited)	5
	Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2024 and 2023 (unaudited)	5-6
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited)	6
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (unaudited)	7
	Notes to Condensed Consolidated Financial Statements (unaudited)	78
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2120
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2526
Item 4.	Controls and Procedures	2526
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	26
Item 1A.	Risk Factors	26
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2627
Item 3.	Defaults Upon Senior Securities	2627
Item 4.	Mine Safety Disclosures	2627
Item 5.	Other Information	2627
Item 6.	Exhibits	27
	Signatures	28

PART I

ITEM 1. FINANCIAL STATEMENTS

METALERT INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2024			December 31, 2023
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	86,095		$	68,440
Accounts receivable, net		25,040			17,408
Inventory		236,639			231,818
Investment in marketable securities		649			649
Other current assets		4,282			4,339
Total current assets		352,705			322,654
Property and equipment, net		20,445			25,780
Intangible assets, net		248,142			261,761
Total assets	$	621,292		$	610,195
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	221,109		$	264,671
Accrued expenses		135,074			327,338
Accrued expenses, related parties		1,019,720			762,365
Deferred revenues		7,699			6,505
Short-term debt – line of credit		98,064			102,040
Short-term debt - CARE loans		14,236			12,972
Convertible promissory notes, net of discount		1,473,500			1,484,142
Convertible notes, related parties, net of discount		1,226,426			1,219,313
Notes payable		146,195			146,195
Notes payable – related parties		46,500			46,500
Total current liabilities		4,388,523			4,372,041
Long-term debt - CARE loan		135,764			137,028
Total liabilities		4,524,287			4,509,069
Commitments and contingencies		-			-
Stockholders’ deficit:
Preferred stock series A, $0.001 par value; 1,000,000 shares authorized; 13,846 shares issued and outstanding at March 31, 2024 and December 31, 2023		14			14
Preferred stock series B, $0.001 par value; 10,000 shares authorized, 3 and 3 issued and outstanding at March 31, 2024 and December 31, 2023, respectively		-			-
Preferred stock series C, $0.001 par value; 1,000 shares authorized, 6 and 6 issued and outstanding at March 31, 2024 and December 31, 2023, respectively		-			-
Preferred stock series D, $0.001 par value; 100,000 shares authorized, 75,000 and 15,000 issued and outstanding at March 31, 2024 and December 31, 2023, respectively		8			2
Preferred stock value		8			2
Common stock, $0.0001 par value; 2,071,000,000 shares authorized; 33,845,931 and 32,445,931 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively		3,385			3,245
Additional paid-in capital		25,091,372			24,844,494
Accumulated deficit		(28,997,774	)		(28,746,629	)
Total stockholders’ deficit		(3,902,995	)		(3,898,874	)
Total liabilities and stockholders’ deficit	$	621,292		$	610,195

(Unaudited)

	June 30, 2024			December 31, 2023

ASSETS
Current assets:
Cash and cash equivalents	$	29,576		$	68,440
Accounts receivable, net		17,240			17,408
Inventory		226,720			231,818
Investment in marketable securities		649			649
Other current assets		5,801			4,339
Total current assets		279,986			322,654

Intangible assets, net		233,972			261,761
Property and equipment, net		12,650			25,780

Total assets	$	526,608		$	610,195

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	173,261		$	264,671
Accrued expenses		188,613			327,338
Accrued expenses, related parties		1,028,105			762,365
Accrued expenses		188,613			327,338
Deferred revenues		8,004			6,505
Short-term debt – line of credit		94,020			102,040
Short-term debt - CARE loans		15,500			12,972
Convertible promissory notes, net of discount		1,518,000			1,484,142
Convertible notes, related parties, net of discount		1,230,762			1,219,313
Convertible promissory notes, net of discount		1,518,000			1,484,142
Notes payable		146,195			146,195
Notes payable – related parties		46,500			46,500
Notes payable		146,195			146,195
Total current liabilities		4,448,960			4,372,041

Long-term debt - CARE loan		134,500			137,028

Total liabilities		4,583,460			4,509,069

Commitments and contingencies		-			-

Stockholders’ deficit:
Preferred stock series A, $0.001 par value; 1,000,000 shares authorized; 13,846 shares issued and outstanding at June 30, 2024 and December 31, 2023		14			14
Preferred stock series B, $0.001 par value; 10,000 shares authorized, 2 and 2 issued and outstanding at June 30, 2024 and December 31, 2023, respectively		-			-
Preferred stock series C, $0.001 par value; 1,000 shares authorized, 6 and 6 issued and outstanding at June 30, 2024 and December 31, 2023, respectively		-			-
Preferred stock series D, $0.001 par value; 100,000 shares authorized, 75,000 and 15,000 issued and outstanding at June 30, 2024 and December 31, 2023, respectively		8			2
Preferred stock		8			2
Common stock, $0.0001 par value; 2,071,000,000 shares authorized; 33,845,931 and 32,445,931 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively		3,385			3,245
Additional paid-in capital		25,091,372			24,844,494
Accumulated deficit		(29,151,631	)		(28,746,629	)
Total stockholders’ deficit		(4,056,852	)		(3,898,874	)
Total liabilities and stockholders’ deficit	$	526,608		$	610,195

See accompanying notes to condensed consolidated financial statements.

METALERT INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	2024			2023			2024			2023
	Three Months Ended March 31,
	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Product sales	$	2416,~~942~~607		$	5436,~~391~~232		$	41,549		$	90,623
Service income		2327,~~376~~556			1812,~~302~~607			50,932			30,909
Licensing income		-			-
Total revenues		44,163			48,839			92,481			121,532
Total revenues		48,318			72,693
Cost of products sold		11,851			40,719			16,326			66,781
Cost of products sold		4,474			26,063
Cost of other revenue		3,082			2,594			3,737			6,899
Cost of service revenue		655			4,305
Total cost of goods sold		14,933			43,313			20,063			73,680
Cost of licensing revenue		-			-
Gross margin		29,230			5,526			72,418			47,852
Total cost of goods sold		5,129			30,368
Operating expenses:
Gross margin		43,189			42,325
Wages and benefits		48,918			118,849			131,801			242,494
Operating expenses:
Professional fees		11,138			20,399			67,420			51,923
Wages and benefits		82,883			123,645
Sales and marketing expenses		3,075			-			10,859			(20	)
Professional fees		56,282			31,524
General and administrative		53,693			47,569			125,939			113,458
Sales and marketing expenses		7,785			-
Total operating expenses		116,824			186,817			336,019			407,855
General and administrative		72,246			65,869
Loss from operations		(87,594	)		(181,291	)		(263,601	)		(360,003	)
Total operating expenses		219,196			221,038
Other income/(expenses):
Loss from operations		(176,007	)		(178,713	)
Gain/(loss) on settlement of debt		-			44,217			-			44,217
Other income (expenses):
Gain/(loss) on marketable securities		-			-			-			(34	)
Gain/loss on settlement of debt		-			-
Amortization of debt discount		(8,836	)		(21,165	)		(20,236	)		(42,219	)
Gain/loss on marketable securities		-			(34	)
Interest expense and financing costs		(57,428	)		(50,345	)		(121,165	)		(99,691	)
Amortization of debt discount		(11,400	)		(21,054	)
Total other income/(expenses)		(66,264	)		(27,293	)		(141,401	)		(97,727	)
Grant from Care loans		-			-
Net loss		(153,858	)		(208,584	)		(405,002	)		(457,730	)
Interest expense and financing costs		(63,738	)		(49,345	)
Net loss attributable to common shareholders	$	(153,858	)	$	(208,584	)	$	(405,002	)	$	(457,730	)
Total other income (expenses)		(75,138	)		(70,433	)
Weighted average number of common shares outstanding - basic and diluted		33,845,931			22,896,968			33,672,305			22,096,739
Net income (loss)	$	(251,145	)	$	(249,146	)
Net income/(loss) per common share - basic and diluted	$	(0.00	)	$	(0.02	)	$	(0.01	)	$	(0.02	)
Weighted average number of common shares outstanding - basic and diluted		33,498,678			21,287,618
Net income (loss) per common share - basic and diluted	$	(0.01	)	$	(0.01	)

See accompanying notes to condensed consolidated financial statements.

METALERT INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

Three Months Ended ~~March~~June 3130, 2024 and ~~March~~June 3130, 2023 (Unaudited)

For the Three Months Ended ~~March~~June 3130, ~~2023~~2024 (Unaudited)

	Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Capital		Deficit			(Deficit)
	Series A Preferred				Series B Preferred				Series C Preferred				Series D Preferred				Common Shares				~~Additional~~
	Shares				Shares				Shares				Shares				Shares				Additional Paid-In		Accumulated			~~Equity~~Total Stockholders’
	Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Capital		Deficit			(Deficit)
Balance December 31, 2023		13,846	$	14		3	$	-		6	$	-	-	15,000		2		32,445,931	$	3,245	$	24,844,494	$	(28,746,629	)	$	(3,898,874	)
Balance March 31, 2024		13,846	$	14		3	$	-		6	$	-		75,000	$	8		33,845,931	$	3,385	$	25,091,372	$	(28,997,774	)	$	(3,902,995	)
Issuance of common stock for services		-		-		-		-		-		-	-	-		-		~~1,400,000~~-		~~140~~-		~~46,884~~-		-			~~47,024~~-
Issuance of preferred stock for financings		-		-		-		-		-		-	-	~~60,000~~-		6-		-		-		~~199,994~~-		-			~~200,000~~
Net income (loss)		-		-		-		-		-		-	-	-		-		-		-		-		(~~251~~153,~~145~~858	)		(~~251~~153,~~145~~858	)
Balance March 31, 2024		13,846	$	14		2	$	-		6	$	-	-	75,000		8		33,845,931	$	3,385	$	25,091,372	$	(28,997,774	)	$	(3,902,995	)
Balance June 30, 2024		13,846	$	14		3	$	-		6	$	-		75,000	$	8		33,845,931	$	3,385	$	25,091,372	$	(29,151,631	)	$	(4,056,852	)

For the Three Months Ended ~~March~~June 3130, ~~2022~~2023 (Unaudited)

	Series A Preferred				Series B Preferred				Series C Preferred				Series D Preferred				Common Shares				~~Additional~~
	Shares				Shares				Shares				Shares				Shares				Additional Paid-In		Accumulated			~~Equity~~Total Stockholders’
	Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Capital		Deficit			(Deficit)
Balance December 31, 2022		13,846	$	14		2	$	-		19	$	-		-		-		17,179,794	$	1,718	$	24,241,862	$	(27,556,471	)	$	(3,312,877	)
Balance March 31, 2023		13,846	$	14		3	$	-		6	$	-		-	$	-		22,833,465	$	2,283	$	24,297,833	$	(27,805,617	)	$	(3,505,487	)
Beginning balance		13,846	$	14		2	$	-		19	$	-		-		-		17,179,794	$	1,718	$	24,241,862	$	(27,556,471	)	$	(3,312,877	)
Issuance of common stock for the conversion of notes		-		-		-		-		-		-		-		-		577,877		58		5,721		-			5,779
Issuance of common stock for the conversion of notes		-		-		-		-		-		-		-		-		5,653,671		565		55,971		-			56,536
Net income (loss)		-		-		-		-		-		-		-		-		-		-		-		(208,584	)		(208,584	)
Net income (loss)		-		-		-		-		-		-		-		-		-		-		-		(249,146	)		(249,146	)
Balance June 30, 2023		13,846	$	14		3	$	-		6	$	-		-	$	-		23,411,342	$	2,341	$	24,303,554	$	(28,014,201	)	$	(3,708,292	)
Balance March 31, 2023		13,846	$	14		2	$	-		19	$	-		-		-		22,833,465	$	2,283	$	24,297,833	$	(27,805,617	)	$	(3,505,487	)
Ending balance		13,846	$	14		2	$	-		19	$	-		-		-		22,833,465	$	2,283	$	24,297,833	$	(27,805,617	)	$	(3,505,487	)

The accompanying notes are an integral part of these consolidated financial statements.

METALERT INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

Six Months Ended June 30, 2024 and June 30, 2023 (Unaudited)

For the Six Months Ended June 30, 2024 (Unaudited)

	Series A Preferred				Series B Preferred				Series C Preferred				Series D Preferred				Common Shares
	Shares				Shares				Shares				Shares				Shares				Additional Paid-In		Accumulated			Total Stockholders’
	Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Capital		Deficit			Deficit
Balance December 31, 2023		13,846	$	14		3	$	-		6	$	-		15,000	$	2		32,445,931	$	3,245	$	24,844,494	$	(28,746,629	)	$	(3,898,874	)

Issuance of common stock for services		-		-		-		-		-		-		-		-		1,400,000		140		46,884		-			47,024
Issuance of preferred stock for financings		-		-		-		-		-		-		60,000		6		-		-		199,994		-			200,000
Net income (loss)		-		-		-		-		-		-		-		-		-		-		-		(405,002	)		(405,002	)
Balance June 30, 2024		13,846	$	14		3	$	-		6	$	-		75,000	$	8		33,845,931	$	3,385	$	25,091,372	$	(29,151,631	)	$	(4,056,852	)

For the Six Months Ended June 30, 2023 (Unaudited)

	Series A Preferred				Series B Preferred				Series C Preferred				Series D Preferred				Common Shares
	Shares				Shares				Shares				Shares				Shares				Additional Paid-In		Accumulated			Total Stockholders’
	Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Issued		Amount		Capital		Deficit			Deficit
Balance December 31, 2022		13,846	$	14		3	$	-		6	$	-		-		-		17,179,794	$	1,718	$	24,241,862	$	(27,556,471	)	$	(3,312,877	)
Beginning balance		13,846	$	14		3	$	-		6	$	-		-		-		17,179,794	$	1,718	$	24,241,862	$	(27,556,471	)	$	(3,312,877	)
Issuance of common stock for the conversion of notes		-		-		-		-		-		-						6,231,548		623		61,692		-			62,315
Net income (loss)		-		-		-		-		-		-		-		-		-		-		-		(457,730	)		(457,730	)
Balance June 30, 2023		13,846	$	14		3	$	-		6	$	-		-		-		23,411,342	$	2,341	$	24,303,554	$	(28,014,201	)	$	(3,708,292	)
Ending balance		13,846	$	14		3	$	-		6	$	-		-		-		23,411,342	$	2,341	$	24,303,554	$	(28,014,201	)	$	(3,708,292	)

The accompanying notes are an integral part of these consolidated financial statements.

METALERT INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	2024			2023
	Three Months Ended March 31,
	Six Months Ended June 30,
	2024			2023
Cash flows from operating activities
Net income / (loss)	$	(251,145	)	$	(249,146	)
Net loss	$	(405,002	)	$	(457,730	)
Adjustments to reconcile net income / (loss) to net cash used in operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		2143,~~954~~919			816,~~335~~670
Change in fair value of marketable securities		-			34
Stock based compensation		47,024			-
Grant from CARE loans		-			-
Amortization of debt discount		20,236			42,219
Amortization of debt discount		11,401			21,054
Gain on the settlement of debt and accrued interest		-			27,537
Loss on the settlement of debt and accrued interest		-			-
Gain on extinguishment of debt		-			16,680
Bonus shares issued		-			-
Payment proceeds against loan		-			-
Changes in operating assets and liabilities:
Accounts receivable		~~(7,632~~168	)		~~(14~~1,~~460~~038	)
Inventory		(45,~~821~~098	)		~~603~~13,647
Other current and non-current assets		57(1,463	)		3,275
Accounts payable and accrued expenses		(~~235~~230,~~826~~134	)		~~(16~~113,~~709~~980	)
Accrued expenses - related parties		~~257~~209,~~355~~438			~~104~~132,~~687~~654
Accrued interest and financing costs		-56,302			61(94,~~201~~518	)
Deferred revenues		1,~~194~~499			(36,~~175~~300	)
Due to/from Officers		-			35,000
Net cash used in operating activities		(~~160~~252,~~439~~915	)		(49155,~~301~~814	)
Cash flows from investing activities
PP&E purchases		(3,000	)		-
Property, plant and equipment purchases		(3,000	)		-
Proceeds from the sale of marketable securities		-			-
Net cash used in investing activities		(3,000	)		-
Cash flows from financing activities
Proceeds from line of credit		-			746,~~000~~881
Proceeds from issuance of preferred stock		200,000			-
Proceeds from sale of preferred stock		200,000			-
Proceeds from the exercise of warrants		-			-
Proceeds from the issuance of debt		40,000			190,000
Proceeds from the issuance of debt		-			65,000
Payments on line of credit		(8,019	)		(27,791	)
Payments on notes		(14,930	)		-
Payments on debt		(14,930	)		(16,722	)
Payments on debt		(3,976	)		(26,563	)
Net cash provided by financing activities		217,051			192,368
Net cash provided by financing activities		181,094			45,437
Net change in cash and cash equivalents		(38,864	)		36,554
Net change in cash and cash equivalents		17,655			(3,864	)
Cash and cash equivalents, beginning of period		68,440			8,535
Cash and cash equivalents, end of period	$	8629,~~095~~576		$	445,~~671~~089
Supplemental disclosure of cash flow information:
Income taxes paid	$	-		$	-
Interest paid	$	-		$	-
Supplemental disclosure of noncash investing and financing activities:
Issuance of common stock for conversion of debt and interest	$	-		$	5662,~~536~~315
Debt discount on convertible notes	$	-8,000		$	7,150
Conversion of preferred stock to common stock	$	-		$	-

See accompanying notes to condensed consolidated financial statements.

METALERT INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE ~~THREE~~SIX MONTHS ENDED ~~MARCH~~JUNE 3130, 2024 AND 2023

(Unaudited)

1. ORGANIZATION AND BASIS OF PRESENTATION

During the periods covered by these financial statements, MetAlert, Inc. and its subsidiaries (the “Company”, “MetAlert”, “we”, “us”, and “our”) were engaged in business operations that design, manufacture and sell various interrelated and complementary products and services in the wearable technology and Personal Location Services marketplace. MetAlert owns 100% of the issued and outstanding capital stock of its two subsidiaries - Global Trek Xploration, Inc., Level 2 Security Products, Inc.

Global Trek Xploration, Inc. is a wearable technology company which designs, manufactures, sells, and distributes tracking and remote patient monitoring solutions for humans., ~~Utilizing~~by utilizing patent protected proprietary hardware, software, connectivity, Global Positioning System (“GPS”) and Bluetooth Low Energy (“BLE”) monitoring and tracking platform, which provides real-time tracking and monitoring of people. Utilizing a miniature quad-band GPRS transceiver, antenna, circuitry, battery and inductive charging pad our solutions can be customized and integrated into numerous products whose location and movement can be monitored in real time over the Internet through our 24x7 tracking portal or on a web enabled cellular telephone. Our core products and services are supported by an IP portfolio of patents, patents pending, registered trademarks, copyrights, URL’s and a library of software source code, all of which is managed by Global Trek.

Level 2 Security Products, Inc. is in the high value non-human asset monitoring and recovery business for items such as firearms, vehicles, bikes, boats, ATVs, and a host of other valuable mobile assets which require oversight monitoring and theft recovery.

LOCiMOBILE, Inc’s, digital assets are now under the management of the parent company MetAlert and remain there, post dissolution, of the corporate entity (LOCiMobile, Inc.). The Company’s digital platform which has been at the forefront of Smartphone application (“App”) development since 2008 designs mobile applications that turn the iPhone, iPad, Android and other GPS enabled handsets into a tracking device which can then be tracked from any mobile device or through our proprietary tracking portal or on any connected device with internet access.

Basis of Presentation

The accompanying unaudited consolidated financial statements of MetAlert have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and applicable regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of financial position and results of operations have been included. Our operating results for the ~~three~~six months ended ~~March~~June 3130, 2024 are not necessarily indicative of the results that ~~may~~ may be expected for the year ending December 31, 2024. The accompanying unaudited consolidated financial statements should be read in ~~conjunction~~ conjunction with our audited consolidated financial statements for the year ended December 31, 2023, which are included in our Annual Report on Form 10-K.

The accompanying consolidated financial statements reflect the accounts of MetAlert, Inc. and its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated.

Going Concern

The consolidated financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its ~~assets~~ assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company ~~has~~incurred ~~a stockholders’~~losses ~~deficit~~and ofnegative $3cash flows from operations during the period ended June 30,~~902,995~~ 2024 and has negative working capital of $4,~~035~~168,~~818~~ 974 as of ~~March~~June 3130, 2024 and used cash in operations during the period then ended. The Company anticipates further losses in the development of its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan until such time as revenues and related cash flows are sufficient to fund our operations.

7The Company’s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

The ~~Company’s~~ability ~~independent~~to ~~registered~~continue ~~public~~as ~~accounting~~a ~~firm~~going ~~has~~concern ~~also~~is ~~included~~dependent ~~explanatory~~upon ~~language in their opinion accompanying~~ the Company’s ~~audited~~generating ~~financial~~profitable ~~statements~~operations ~~for~~in the ~~year~~future ~~ended~~and/or ~~December 31, 2023. The Company’s financial statements do not include~~obtaining ~~any~~the ~~adjustments~~necessary financing to ~~reflect~~meet ~~the~~its ~~possible~~obligations ~~future~~and ~~effects~~repay onits ~~the~~liabilities ~~recoverability~~arising ~~and~~from ~~classification~~normal ofbusiness ~~assets~~operations orwhen ~~the~~they ~~amounts~~come ~~and classifications~~due. ofThe ~~liabilities~~Company’s ~~that~~ability ~~may~~to ~~result~~raise ~~from~~additional ~~the~~capital ~~possible~~through ~~inability of~~ the ~~Company~~future toissuances ~~continue~~of asdebt aor ~~going~~equity ~~concern~~is unknown.

The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company’s ability to raise additional capital through the future issuances of debt or equity is unknown. The ability to obtain additional financing, the successful development of the Company’s contemplated plan of operations, or its ability to achieve profitable operations are necessary for the Company to continue operations, and there is no assurance that these can be achieved. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.8

2. SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

The Company recognizes revenue in accordance with ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied.

We derive our revenues primarily from hardware sales, subscription services fees, IP licensing and professional services fees. Hardware includes our SmartSole, ~~GunTracker~~GunAlert, Military and other Stand-Alone Devices. Subscription services revenues consist of fees from customers accessing our Geo-Location cloud-based platform through subscription or license fee, that are billed monthly, quarterly, semi-annual or annually. Predominately most of our subscriptions at this time are billed monthly and recognized at the time of billing. Professional services and other revenues consist primarily of fees from implementation services, configuration, data services, training and managed services related to our solutions, which are also recognized at the time of billing once the service has been performed/delivered IP licensing is related to any agreement with 3rd parties to license our IP portfolio and that revenue is recognized as per the term of the specific licensing agreements.

The Company’s initial point of contact with its retail customers is thru its e-commerce site whereby any contract with the customer is entered into and dealt with thru the online ordering process and does not require performance beyond delivery. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time.

The Company’s recognizes revenues with its wholesale customers, as with retail, upon shipment, and recurring subscription revenue is recognized at the time of billing which is done 30 days in the arrears from delivery of service. Rendering the service obligation fulfilled

Product sales

At the inception of each customer sale, either online or through a purchase order, we assess the goods and services promised in our contracts and identify each distinct performance obligation. The Company recognizes revenue upon the transfer of control of promised products or services to the customer in an amount that depicts the consideration the Company expects to be entitled to for the related products or services. For the large majority of the Company’s sales, transfer of control occurs once the product has shipped and title and risk of loss have transferred to the customer.

Services Income

The Company’s software solutions are available for use as hosted application arrangements under subscription fee agreements without licensing perpetual rights to the software. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company’s solution is made available to the customer. Our subscription contracts are generally one to three months in length. Amounts that have been invoiced are recorded in accounts receivable and deferred revenues or revenues, depending on whether the revenue recognition criteria have been met.

Other revenue can include various items, such as our professional services arrangements that are recognized on a time and materials basis. Professional services revenues recognized on a time and materials basis are measured monthly based on time incurred and contractually agreed upon rates. Certain professional services revenues are based on fixed fee arrangements and revenues are recognized based on the proportional performance method. In some cases, the terms of our time and materials and fixed fee arrangements may require that we defer the recognition of revenue until contractual conditions are met. Data services and training revenues are generally recognized as the services are performed. Additionally, we have had non-compete revenue from the sale of assets, engineering, and design work, all of which are recognized over the term of the agreed contracts.

~~Royalty revenue from a non-compete agreement expired in June of 2023.~~9

Licensing Revenue

Licensing revenue recorded by the Company relates exclusively to the Company’s monetization of IP licenses. The Company recognizes revenue for licensing under ASC 606, which provides revenue recognition constraints by requiring the recognition of revenue at the later of the following: 1) sale or usage of the products or 2) satisfaction of the performance obligations. The Company has satisfied its performance obligations and therefore recognizes licensing revenue when the sales to which the licensing relate are completed, under the terms of the specific licensing agreement.

During the period ended March 31, 2024, the Company did not recognize any revenue on settlements.

Disaggregation of Net Sales

The following table shows the Company’s disaggregated net sales by product type:

SCHEDULE OF DISAGGREGATION OF NET SALES

	March 31, 2024		March 31, 2023
	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023
Product sales	$	2441,~~942~~549	$	5490,~~391~~623
Service income		2350,~~376~~932		1830,~~302~~909
IP and consulting income		-		-
Total	$	92,481	$	121,532
Total	$	48,318	$	72,693

The following table shows the Company’s disaggregated net sales by customer type:

	March 31, 2024		March 31, 2023
	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023
B2B	$	3255,~~809~~455	$	5777,~~680~~921
B2C		2537,~~509~~026		1543,~~013~~611
Military		-		-
Total	$	92,481	$	121,532
IP		-		-
Total	$	48,318	$	72,693

Allowance for Doubtful Accounts

We extend credit based on our evaluation of the customer’s financial condition. We carry our accounts receivable at net ~~realizable~~ realizable value. We monitor our exposure to losses on receivables and maintain allowances for potential losses or adjustments. We determine these allowances by (1) evaluating the aging of our receivables; and (2) reviewing high-risk ~~customers~~customer’s financial condition. Past due receivable balances are written off when our internal collection efforts have been unsuccessful in collecting the amount due. Our allowance for doubtful accounts was $11,599 as of ~~March~~June 3130, 2024 and ~~$11,599 as of~~ December 31, 2023., ~~The allowance fully reserves our accounts receivable balances over 90 days~~respectively.

Shipping and Handling Costs

Shipping and handling costs are included in cost of goods sold in the accompanying consolidated statements of operations.

Product Warranty

The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ~~ninety~~ ninety days of purchase. The Company’s warranties are of an assurance-type and come standard with all Company products to cover repair or replacement should product not perform as expected. Provisions for estimated expenses related to product warranties are made at the time products are sold. These estimates are established using historical information about the nature, frequency and average cost of warranty claim settlements as well as product manufacturing and recovery from suppliers. Management actively studies trends of warranty claims and takes action to improve product quality and minimize warranty costs. The Company estimates the actual historical warranty claims coupled with an analysis of unfulfilled claims to record a liability for specific warranty purposes. As of ~~March~~June 3130, 2024 and December 31, 2023, products returned for repair or replacement have been immaterial. Accordingly, a warranty liability has not been deemed necessary.

Use of Estimates

The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.

Fair Value Estimates

Pursuant to the Accounting Standards Codification (“ASC”) No. 820, “Disclosures About Fair Value of Financial Instruments”, the Company records its financial assets and liabilities at fair value. ASC No. 820 provides a framework for measuring fair value, clarifies the definition of fair value and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. ASC No. 820 establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

	Level 1 -	Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

	Level 2 -	Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the asset/liability’s anticipated life.

	Level 3 -	Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

The carrying values for cash and cash equivalents, accounts receivable, investment in marketable securities, other current assets, accounts payable and accrued liabilities approximate their fair value due to their short maturities. The carrying values of notes payable and other financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

Principles of Consolidation

The ~~accompanying~~ ~~condensed~~ consolidated financial statements atinclude ~~March~~the ~~31,~~accounts ~~2024~~of ~~and~~the ~~December~~Company ~~31, 2023~~ and ~~for~~its ~~the~~wholly ~~years~~owned ~~then~~subsidiaries. ~~ended include~~All ~~the~~intercompany accounts ofand ~~MetAlert,~~transactions ~~Inc.~~have ~~and~~been eliminated in the ~~following~~consolidated ~~majority-owned~~financial ~~subsidiaries~~statements herein.

SCHEDULE OF MAJORITY- OWNED SUBSIDIARIES

Subsidiary:	Percentage Owned
	March 31, 2024			December 31, 2023
Global Trek Xploration		100.00	%		100.00	%
Level 2 Security Products, Inc. (see Footnote 5)		100.00	%		100.00	%

All Intercompany transactions have been eliminated upon consolidation.

Concentrations

We ~~can~~ currently rely on ~~one or~~ two manufacturers to supply us with our GPS SmartSole, ~~in Germany~~ and ~~the~~two ~~U.S.~~manufacturers ~~Currently, for the Gun Tracker we have one supplier in China, but in order~~ to ~~have~~supply ~~redundances~~us wewith ~~are~~the ~~looking~~GPS ~~for~~device ~~sources~~included in the USGPS ~~and Mexico for manufacturing~~SmartSole. ~~However,~~The ~~the~~ loss of ~~any~~either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole ~~and Gun Tracker, and thus as we increase production we are looking to augment and grow our vendors and supply chains accordingly~~.

~~As of~~We ~~March~~currently ~~31,~~rely ~~2024,~~on ~~the~~one ~~Company~~manufacturer ~~had~~to ~~four~~supply ~~customers~~us ~~representing~~with ~~approximately~~our ~~9%,~~GPS ~~8%, 5%~~ GunAlert and ~~55%~~one ofmanufacturer ~~sales~~to ~~and~~supply ~~four~~us ~~customers~~with ~~representing approximately~~the ~~39%,~~GPS ~~10%,~~device ~~10%~~included ~~and~~in 9%the ofGPS ~~total accounts receivable, respectively~~GunAlert. The ~~Company~~loss ~~had~~of ~~four~~this ~~customers representing approximately~~manufacturer ~~29%,~~could ~~16%,~~severely ~~16%~~impede ~~and~~our 15ability ofto ~~sales~~manufacture ~~and four customers representing approximately 45%, 14%, 11% and 7% of total accounts receivable, respectively, for~~ the ~~period~~GunAlert ~~ended~~tracking ~~March 31, 2023~~solution.

As of June 30, 2024, the Company had four customers representing approximately 36%, 19%, 17% and 12% of sales, respectively, and three customers representing approximately 33%, 12%, and 11% of total accounts receivable, respectively. As of June 30, 2023, the Company had four customers representing approximately 29%, 29%, 15% and 14% of sales, respectively, and two customers representing approximately 14%, and 8% of total accounts receivable, respectively.

Stock-based Compensation

The Company accounts for share-based awards to employees and ~~nonemployees~~nonemployee directors and consultants in accordance with the provisions of ~~ASC~~ ASC 718, Compensation—Stock Compensation., ~~and under the recently issued guidance following FASB’s pronouncement, ASU 2018-07, Compensation—Stock Compensation~~ (~~Topic~~“ASC 718”)~~: Improvements to Nonemployee Share-Based Payment Accounting~~. Under ASC 718, ~~and applicable updates adopted,~~ share-based awards are valued at fair value on the date of grant and that fair value is recognized over the requisite service, or vesting, period. The Company values its equity awards using the Black-Scholes option pricing model, and accounts for forfeitures when they occur.

Marketable Securities

The Company’s securities investments that are acquired and held principally for the purpose of selling them in the near term are classified as trading securities. Trading securities are recorded at fair value based on quoted market price (level 1) on the balance sheet in current assets, with the change in fair value during the period included in earnings. As of ~~March~~June 3130, 2024 and December 31, 2023 the fair value of our investment in marketable securities was $649 ~~and $649, respectively~~.

11Derivative Liabilities

Our derivative instrument liabilities are re-valued at the end of each reporting period, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur. For bifurcated conversion options that are accounted for as derivative instrument liabilities, we determine the fair value of these instruments using the Black-Scholes option pricing model. This model requires assumptions related to the remaining term of the instrument and risk-free rates of return, our current Common Stock price and expected dividend yield, and the expected volatility of our Common Stock price over the life of the option.

At June 30, 2024 and December 31, 2023, the balance of the derivative liabilities was $0. It was determined at December 31, 2020 that the Preferred A shareholders having the majority vote, can agree to increase the number of authorized shares, if needed, to settle any convertible debt, and thus the liability is $0.

Net Loss Per Common Share

Basic loss per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of outstanding common shares during the period. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted unless they are antidilutive. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

	2024		2023
	March 31,
	June 30,
	2024		2023
Warrants		~~628~~200,~~205~~000		~~603~~746,~~846~~154
Preferred B shares		18,462		17,046
Preferred C shares		6,154		10,390
Preferred D shares		7,500,000		-
Conversion shares upon conversion of notes		114,~~372~~808,~~483~~847		8388,~~935~~266,~~166~~791
Total		122,~~525~~533,~~304~~463		8489,~~566~~040,~~448~~381

Segments

The Company operates in one segment for the manufacture and distribution of its products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

Recently Issued Accounting Pronouncements

InThere ~~June~~are ~~2016,~~other ~~the~~new ~~FASB~~accounting pronouncements issued ~~ASU~~by ~~No.~~the ~~2016-13,~~FASB ~~Credit~~that ~~Losses~~the -Company ~~Measurement~~has ofadopted ~~Credit~~or ~~Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities~~ will ~~measure~~adopt, ~~credit~~as ~~losses for most financial assets~~applicable, ~~including accounts~~ and ~~notes~~the ~~receivables.~~Company ~~The~~does ~~standard~~not ~~will~~believe ~~replace~~any ~~today’s~~of ~~“incurred~~these ~~loss”~~accounting ~~approach~~pronouncements ~~with~~have ~~an “expected loss” model~~had, ~~under~~or ~~which companies~~ will ~~recognize~~have, ~~allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as~~ a ~~cumulative-effect adjustment~~material toimpact ~~retained~~on ~~earnings~~its asconsolidated offinancial ~~the beginning of the first reporting period in which the guidance is effective. As small business~~statements ~~filer,~~or ~~the standard will be effective for us for interim and annual reporting periods beginning after December 15, 2022~~disclosures.

Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

3. INVESTMENT IN MARKETABLE SECURITIES

The Company’s investments ininclude marketable securities ~~is comprised~~ of ~~shares of stock of~~ two ~~(2)~~ entities ~~with~~whereby ~~ownership~~the ~~percentages~~Company’s ofownership is less than 5%. ~~The~~As ~~Company~~of ~~accounted~~June ~~for these investments pursuant to ASU 320~~30, ~~Investments~~2024 ~~– Debt~~ and ~~Equity~~December ~~Securities. As such~~2023, ~~these~~ ~~investments~~the securities were ~~recorded~~valued at ~~their market value as of December 31~~$649, ~~2019, with the change in fair value being reflected in the statement of operations~~respectively. ~~These investments consisted of the following:~~

As of December 31, 2022, the Company owned 42,500 shares of Inventergy Global, Inc. common stock with a fair value of $638. The Company was able to obtain observable evidence that the investment had a market value of $0.015 per share, or an aggregate value of $638 as of the period ended March 31, 2024. As such, the Company recorded no change in market value during the three months ended March 31, 2024, in its statement of operations.

In June 2019, the Company acquired 22,222 shares of Inpixon’s restricted common stock (after giving effect to a 1:45 stock split) valued at $634,000. As of December 31, 2019, after the sale of 10,889 Inpixon shares, the Company owned 11,333 Inpixon shares with a fair value of $58,374. During the period ended March 31, 2020, the Company sold 8,500 of its Inpixon shares for total proceeds of $146,201 and recognized a gain from the sale of these shares of $102,420.

During the period ended December 31, 2021, the Company sold 834 of its Inpixon shares for total net proceeds of $1,258. The Company was able to obtain observable evidence that the remaining 2,000 shares had a market value of $2,040 as of December 31, 2021, as such, the Company recorded a loss from the decrease in the fair value of the shares of $851, resulting in a net loss from their investment in Inpixon shares during the current period ended December 31, 2021.

During the period ended December 31, 2022, the Company shares were reversed down to 27 shares. The Company was able to obtain observable evidence that these 27 shares had a market value of $45 as of December 31, 2021, as such, the Company recorded a loss from the decrease in the fair value of the shares of $1,995, resulting in a net loss from their investment in Inpixon shares during the period ended December 31, 2022.

The Company was able to obtain observable evidence that the remaining 2,000 shares had a market value of $11 as of March 31, 2024, as such, there was no change during the current period ended March 31, 2024.

4. INVENTORY

Inventories consist of the following:

SCHEDULE OF INVENTORY

	March 31, 2024		December 31, 2023
	June 30, 2024		December 31, 2023
Raw materials	$	1413,~~094~~826	$	24,936
Finished goods		~~222~~212,~~545~~894		206,882
Total Inventories	$	~~236~~226,~~639~~720	$	231,818

5. PROPERTY AND EQUIPMENT

Property and equipment, net, consists of the following:

SCHEDULE OF PROPERTY AND EQUIPMENT

	March 31, 2024			December 31, 2023
	June 30, 2024			December 31, 2023
Software	$	25,890		$	25,890
Website development		91,622			91,622
Software development		~~394~~397,772			394,772
Equipment		1,750			1,750
Less: accumulated depreciation		(496,589	)		(488,254	)
Property and equipment, gross		1,750			1,750
Total property and equipment, net	$	20,445		$	25,780
Less: accumulated depreciation		(504,384	)		(488,254	)
Total property and equipment, net	$	12,650		$	25,780

Depreciation expense for the period ended ~~March~~June 3130, 2024 and 2023 was $816,~~335~~130 and $816,~~335~~670, respectively, and is included in general and administrative expenses.

6. INTANGIBLE ASSETS

Intangible assets, net, consists of the following:

SCHEDULE OF INTANGIBLE ASSETS

	March 31, 2024			December 31, 2023
	June 30, 2024			December 31, 2023
Trademarks	$	3,308		$	3,308
Tooling and molds		25,300			25,300
Website development		9,400			9,400
Software development		191,457			191,457
Acquired patents and trademarks		50,000			50,000
Less: accumulated amortization		(31,323	)		(17,704	)
Intangible assets, gross		50,000			50,000
Total intangible assets, net	$	248,142		$	261,761
Less: accumulated amortization		(45,493	)		(17,704	)
Total intangible assets, net	$	233,972		$	261,761

Amortization expense for the period ended ~~March~~June 3130, 2024, and 2023 was $1327,~~619~~789, which included $551 in amortization related to non-Level 2 amortization for trademarks, and $0 respectively, and is included in general and administrative expenses.

As part of the Level 2 Securities LLC acquisition, the Company determined the value of the IP (various tooling, product and software development, trademarks, and patents costs) at this early stage, pre-revenue, by taking the accumulated selected costs, summing them by category, and calculating each categories percent of the total, to come up with a list of capitalizable assets that had value as part of the merger. These accumulated capitalized costs were then applied an obsolescence factor to discount those values, allowing for an arm’s length, non-bargain purchase price. This allocation of the IP was done using the cost approach as the economic benefit to MetAlert are the avoided costs spent to date, and thus would not have to spend those development costs going forward ourselves.

This method is especially relevant when there are no reliable forecasts for the business at date of acquisition or said forecasts would involve a lot of speculation. We then determined that a 5-year amortization period for these assets would be considered reasonable.

7. NOTES &AND LOANS PAYABLE

The following table summarizes the components of our short-term borrowings:

	March 31, 2024		December 31, 2023
	June 30, 2024		December 31, 2023
(a) Term loan	$	146,195	$	146,195
(b) Revolving line of credit		7,000		7,000
(b) Revolving line of credit		9187,~~064~~020		95,040
Total	$	~~244~~240,~~259~~215	$	248,235

(a) Term loans

In 2022, the Company entered into an unsecured short-term loan agreements with various third parties for an aggregate principal balance of $145,000 at an interest rate of 5% per annum, with the interest adjusted to 10% in the case of a default. One loan for $25,000 was paid in full on April 14, 2022, leaving $120,000 outstanding as of ~~March~~December 31, ~~2024~~2022.

In September of 2019, the Company entered into an unsecured term loan agreement with a third party for an aggregate principal balance of $50,000 at an interest rate of 5% per annum in relation to an Asset Purchase Agreement. The term loan became due on December 31, 2020, and is currently past due. The ~~principal~~ balance outstanding on the note as of ~~March~~June 3130, 2024, was $3534,~~488~~176, which included $97,~~293~~981 in interest, $4,500 in cash payments to principal and reductions of $1926,~~305~~195 due to sublet fees for office space and principal payments.

The Company also has an unsecured line of credit, guaranteed by its CEO, with its business bank, Union Bank, whereby funds can be borrowed at a revolving adjustable rate of 2 points over prime, currently 8.25%, with a max borrowing amount of $100,000. The balance at March 31, 2024 and December 31, 2023 was $91,064 and $90,040, respectively, with $0 having been borrowed and $3,975 paid back in the March 31, 2024 period.

(b) Lines of Credit

The Company obtained a revolving line of credit agreement with an accredited investor of $500,000 during 2018. There were three borrowings against the line as of December 31, 2018 for aggregate borrowings of $65,000 and two borrowing in 2019 for $65,000 for a total of $130,000. During the period ended December 31, 2020, the Company repaid $76,000 in principal and all of its accrued interest of $4,204, resulting in a balance due of $22,000 as of December 31, 2020. During the period ended December 31, 2021, the Company repaid $10,000 in principal and all of its interest of $560, as incurred, resulting in a balance due of $7,000 as of December 31, 2021. There were no changes to the line of credit for the period ending March 31, 2024.

The line bears interest of 8.5%. The line is based upon MetAlert providing the investor with purchase orders and use of proceeds, including production of goods schedules and loan repayment timelines. These loans/drawdowns are specifically for product, inventory and/or purchase order financing. Upon completion of the terms of the Line of Credit, MetAlert, Inc. will issue to the investor 7,500,000 shares of MetAlert common stock or $75,000 of MetAlert common stock, whichever is greater.14

The ~~Company~~line ~~also~~bears ~~has~~interest anof ~~unsecured~~8.5%. The line ofis ~~credit,~~based ~~guaranteed~~upon byMetAlert ~~its~~providing ~~CEO,~~the investor with ~~its~~purchase ~~business~~orders ~~bank,~~and ~~Union~~use ~~Bank~~of proceeds, ~~whereby funds can be borrowed~~including atproduction ~~a revolving adjustable rate~~ of 2goods ~~points~~schedules ~~over~~and ~~prime,~~loan ~~currently~~repayment 8timelines.~~25%,~~ ~~with~~These aloans/drawdowns ~~max~~are ~~borrowing~~specifically ~~amount~~for ~~of $100~~product,~~000.~~ ~~The~~inventory ~~balance~~and/or ~~at March~~purchase ~~31,~~order ~~2024~~financing. ~~and~~As ~~December~~if ~~31,~~June ~~2023 was $91~~30,~~065~~ ~~and $95~~2024,~~040,~~ ~~respectively,~~the ~~with~~balance $0is ~~having been borrowed and~~ $37,~~975 paid back in the March 31, 2024 period~~000.

The Company also has an unsecured line of credit, guaranteed by its CEO, with its business bank, Union Bank, whereby funds can be borrowed at a revolving adjustable rate of 2 points over prime, currently 8.25%, with a max borrowing amount of $100,000. The balance at June 30, 2024 and December 31, 2023 was 87,020 and $91,065, with $0 having been borrowed and $8,019 paid back in the June 30, 2024 period.

8. CONVERTIBLE PROMISSORY NOTES

As of ~~March~~June 3130, 2024 and December 31, 2023, the Company had a total of $1,~~473~~518,~~500~~000 and $1,454,142, respectively, of outstanding convertible notes payable, which consisted of the following:

SCHEDULE OF CONVERTIBLE NOTES PAYABLE

	March 31, 2024			December 31, 2023
	June 30, 2024			December 31, 2023
Convertible Notes – with fixed conversion, past due	$	415,500		$	415,500
Convertible Notes – with fixed conversion		~~732~~840,500			732,500
Convertible Notes – with fixed conversion and OID		~~60,000~~-			74,930
Convertible Note – with variable conversion		68,000			68,000
Notes issued in relation to acquisition – with fixed conversion		200,000			200,000
Less: Debt discount		(2,500	)		(6,788	)
Total convertible notes		200,000			200,000
Total convertible notes, net of debt discount	$	1,473,500		$	1,484,142
Less: Debt discount		(6,000	)		(6,788	)
Total convertible notes, net of debt discount	$	1,518,000		$	1,484,142

a) Included in Convertible Notes - with fixed conversion terms, are loans provided to the Company from various investors These notes carry simple interest rates ranging from 0% to 1214% per annum and with terms ranging from 1 to 2 years. In lieu of the repayment of the principal and accrued interest, the outstanding amounts are convertible, at the option of the note holder, generally at any time on or prior to maturity and automatically under certain conditions, into the Company’s common shares at $0.015 to $0.30 per share. These notes became due in 2017 and prior, and are currently past due.

During the twelve months ending December 31, 2023, noteholders converted $31,515 of notes with accrued interest of $4,015 into 31,151,537 shares of common stock. On March 14, 2023, the Company entered into an unsecured short-term loan agreement with a third party for an aggregate of $74,650 with an interest rate of 12%, an original issue discount of $7,150, financing costs of $2,500, with installment payments of $8,361 paid back monthly starting 45 days from the issuance date, with all $6674,~~886~~ 650 of payments having been paid in full as of ~~September 30~~January 31, ~~2023~~2024. This same lender entered into another unsecured note on December 8, 2023, for $68,000 with a 35% discount to market ~~rate~~, if the note ~~was~~is ~~note~~not paid back by September 30, 2024. During the twelve months ended December 31, 2023, an additional $35,000 of the Company’s executive notes were transferred to third parties for cash. The transferred notes had no change in terms thus no resulting gain or loss on the extinguishment and transfer. As per the original terms the notes bear a 10% annual interest rate, gives the holder the right, but not the obligation to convert up to 50% of the amount advanced and accrued interest into shares, warrants or options of common or preferred stock of the Company at fixed rate of $0.01 per share.

During the twelve months ended December 31, 2023, an additional $35,000 of the Company’s executive notes were transferred to third parties for cash. The transferred notes had no change in terms thus no resulting gain or loss on the extinguishment and transfer. As per the original terms the notes bear a 10% annual interest rate, gives the holder the right, but not the obligation to convert up to 50% of the amount advanced and accrued interest into shares, warrants or options of common or preferred stock of the Company at fixed rate of $0.01 per share.

A noteholder invested $125,000 on June 9, 2023, and an additional $35,000 on September 20, 2023, in the Company with convertible notes at a 10% interest rate and a fixed conversion price of $0.04 and $0.05, respectively. On July 25, 2023, and August 30, 2023, a noteholder invested $30,000 each in the Company with convertible notes that have a 17% OID and a fixed conversion price of $0.11. During the twelve months ended December 31, 2023, the Company consolidated various past-due convertible promissory notes in an aggregate amount of $400,000 inclusive of interest at a 12% interest rate and with conversion rates ranging from .30 to $9.75 with an investor into a new single note. The convertible promissory note agreement bears interest at seven (6%) percent, has a one (1) year maturity date. The note may be repaid in whole or in part any time prior to maturity. The promissory note is convertible at the investor’s sole discretion, into common shares at a conversion price of $4.00. The resulting modification of the notes resulted in a forgiveness of accrued interest of $27,537. During the twelve months ended December 31, 2023, the Company issued $200,000 in convertible notes in conjunction with the purchase of Level 2 Securities, LLC. These notes agreements bear an interest rate of 10% and are convertible at the investor’s sole discretion, into common shares at a conversion price of $0.01. As of December 31, 2023, and December 31, 2022, $415,500 and $678,000 of these convertible notes are currently past due, with no associated penalties.

On July 25, 2023, and August 30, 2023, a noteholder invested $30,000 each in the Company with convertible notes that have a 17% OID and a fixed conversion price of $0.11. On June 8, 2024, this same noteholder consolidated their loan into a new $108,000 note with a 20% OID and a fixed conversion price of $0.03.

During the twelve months ended December 31, 2023, the Company consolidated various past-due convertible promissory notes in an aggregate amount of $400,000 inclusive of interest at a 12% interest rate and with conversion rates ranging from .30 to $9.75 with an investor into a new single note. The convertible promissory note agreement bears interest at seven (6%) percent, has a one (1) year maturity date. The note may be repaid in whole or in part any time prior to maturity. The promissory note is convertible at the investor’s sole discretion, into common shares at a conversion price of $4.00. The resulting modification of the notes resulted in a forgiveness of accrued interest of $27,537.

During the twelve months ended December 31, 2023, the Company issued $200,000 in convertible notes in conjunction with the purchase of Level 2 Securities, LLC. These notes agreements bear an interest rate of 10% and are convertible at the investor’s sole discretion, into common shares at a conversion price of $0.01.

As of June 30, 2024, and December 31, 2023 $415,500 of these convertible notes are currently past due, with no associated penalties.

9. CARE Loans

SCHEDULE OF LOANS PAYABLE

	March 31, 2024		December 31, 2023
	June 30, 2024		December 31, 2023
a) EIDL loan – short term	$	14,236	$	12,972
EIDL loan – short term	$	15,500	$	12,972
a) EIDL loan – long term		135,764		137,028
EIDL loan – long term		134,500		137,028
Total CARE loans	$	150,000	$	150,000

~~(a)~~ Economic Injury Disaster Loan

On June 10, 2020, the Company executed a secured loan with the U.S. Small Business Administration (SBA) under the Economic Injury Disaster Loan program in the amount of $150,000. The loan is secured by all tangible and intangible assets of the Company and payable over 30 years at an interest rate of 3.75% per annum. Installment payments, including principal and interest, started in December 2022. As part of the loan, the Company also received an advance of $10,000 from the SBA. While the SBA refers to this program as an advance, it was written into law as a grant. This means that the amount given through this program does not need to be repaid and has been recognized as Other Income.

As of ~~March~~June 3130, 2024, ~~the~~and ~~Company~~December ~~calculated that 34 months of the 360 periods on the 30-year loans should be considered short-term~~31, ~~and as such moved $14~~2024,~~236~~ to short- term ~~liabilities,~~amounts ~~and~~due ~~has~~under ~~accrued interest on~~ the loan ofinclude ~~$23,369~~planned asprinciple ofpayments in ~~March 31, 2024, or until~~ the ~~Company has~~next ~~received~~twelve ~~more~~months ~~definitive~~and ~~correspondence~~any ~~related~~payments toconsidered ~~any~~past ~~potential forgiveness~~due.

10. RELATED PARTY TRANSACTIONS

Convertible Notes Due to Related Parties

During the period ended ~~March~~June 3130, 2024, there was no change in related party notes.

During the period ended December 31, 2023, the related parties converted $40,000 of debt, plus interest, for 4,269,600 shares of common stock. Additionally, the Company’s executives transferred $35,000 of their outstanding employee notes for cash to a third party. Lastly, one executive applied various payments to a note. The transferred notes had no change in terms, thus resulting in no gain or loss on the extinguishment related to the transfer of debt, making the outstanding balance on the related party notes on December 31, 2023, as $1,219,313, net of debt discounts.

16Accrued wages and costs - In order to preserve cash for other working capital needs, various officers, members of management, employees and directors agreed to defer portions of their wages and sometimes various out-of-pocket expenses. As of March 31, 2024, and December 31, 2023, the Company owed $195,791, respectively, for such deferred wages and other expenses owed for other services which are included in the accrued expenses – related parties on the accompanying balance sheet. There were no new related party transactions in the quarter ended June 30, 2024.

Accrued wages and costs - In order to preserve cash for other working capital needs, various officers, members of management, employees and directors agreed to defer portions of their wages and sometimes various out-of pocket expenses since 2011. As of March 31, 2024, and December 31, 2023, the Company owed $195,791, respectively, for such deferred wages and other expenses owed for other services which are included in the accrued expenses – related parties on the accompanying balance sheet. There were no new related party transactions in the quarter ended March 31, 2024.

Officer Loans

On November 18, 2022, an officer loaned the Company $10,000 at a 10% interest rate on a short-term basis.

During the period ended December 31, 2023, the same office loaned another $3,500, was paid $2,000 in principal and $850 in interest, leaving a balance of $11,500 in principal on December 31, 2023.

A second officer loaned the Company $35,000, both at the 10% interest rate, with a total of $2,000 in principal and $850 in interest being paid back during ~~this~~the ~~period~~six months ended June 30, 2024.

For the period ending ~~March~~June 3130, 2024, the outstanding balance on officer loans was $46,500.

11. ~~DERIVATIVE LIABILITIES~~EQUITY

Under authoritative guidance used by the FASB on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock, instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The Company has issued certain convertible notes which conversion prices are based on a future market price. However, since the number of shares to be issued is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to share settle the conversion option. As a result, the conversion option is classified as a liability and bifurcated from the debt host and accounted for as a derivative liability in accordance with ASC 815 and will be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

At March 31, 2024 and December 31, 2023, the balance of the derivative liabilities was $0. It was determined at December 31, 2020 that the Preferred A shareholders having the majority vote, can agree to increase the number of authorized shares, if needed, to settle any convertible debt, and thus the liability is $0.

12. EQUITY

The Company has 10,000,000 shares of preferred stock authorized. From this pool the following preferred shares have been classified as:

Preferred Stock – Series A

~~During~~The ~~the~~Company ~~year~~is ~~ended~~authorized ~~December~~to ~~31,~~issue ~~2018, the Company authorized~~ 1,000,000 of Series A preferred shares, which shares have voting rights equal to two-thirds of all the issued and outstanding shares of common stock. Holders of Series A preferred shares, shall be entitled to vote on all matters of the corporation, and shall have the majority vote of the board of directors. The subject preferred stock lacks any dividend rights, does not have liquidation preference, and is not convertible into common stock. During the year ended December 31, 2018, the Company issued one million shares to certain officers and board members. The Company retained a third-party valuation firm whose input was utilized in determining the related per share valuation of the preferred shares. Based on Management’s assessment and the valuation report, the fair value of the preferred shares was determined to be $0.0463 per share or an aggregate of $46,363. During the fiscal year ended December 31, 2022, 100,000 shares (1,539 with the reverse stock split), were returned to treasury and of the 900,000 shares (13,846 after the reverse stock split) all remain outstanding as of March 31, 2024.

At December 31, 2020 is was determined that the Preferred A shareholders having the majority vote, can agree to increase the number of authorized shares, if needed, to settle any convertible debt, and thus any derivative liabilities are not necessary to reserve for this.

As of all dates presented in these financial statements, it was determined that the Preferred A shareholders having the majority vote, can agree to increase the number of authorized shares, if needed, to settle any convertible debt, and thus any derivative liabilities are not necessary to reserve for this.

Preferred Stock – Series B

~~During~~The ~~the~~Company ~~year~~is ~~ended~~authorized ~~December~~to ~~31,~~issue ~~2019, the Company authorized~~ 10,000 shares of preferred stock to be designated available for Series B preferred shares that have a stated value of $1,000 each and are convertible into common shares at fixed price of $0.0025. Holders shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Preferred Stock equal (on an as~~-if-~~ converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of of the Company’s Common Stock. No other dividends shall be paid on shares of Series B Preferred Stock, and they shall have no voting rights and have liquidation preference. ~~During the year ended December 31, 2019, the Company issued 150 Series Preferred B shares and 30,000,000 warrants to an accredited investor for their financings for an aggregate value of $150,000.~~

During the period ended December 31, 2020, the Company issued 100 Series B preferred shares and 20,000,000 warrants to an accredited investor for their financings for an aggregate value of $50,000. The Series B preferred shares and warrants shall have a fixed conversion price equal to $0.0025 of common stock, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock. The warrants are exercisable at a price of $0.0025 per share through March 2025. The Company considered the accounting effects of the existence of the conversion feature of the Series B Preferred Stock, and the issuance of warrants at the date of issuance. In accordance with the current accounting standards, the Company determined that it should account for the fair value of the conversion feature and relative fair value of the issued warrants (up to the face amount of the Series B Preferred Stock) as a deemed dividend of $50,000 and a charge to paid in capital.

During the period ended December 31, 2021, the two accredited investors converted 70 Series B preferred shares into 28,000,000 common shares at the conversion price of $0.0025, leaving a balance of 180 Series B as of December 31, 2022, which with the reverse stock split leaves a balance of 3 as of December 31, 2023 and as of the period ending March 31, 2024.

Preferred Stock – Series C

~~During~~The ~~the period ended December 31, 2020, the~~ Company authorized to issue 1,000 shares of preferred stock to be designated available for Series C preferred shares that have a stated value of $1,000 each and are convertible into common shares at fixed price of $0.015. Holders shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Preferred Stock equal (on an as~~-if-~~ converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Company’s Common Stock. No other dividends shall be paid on shares of Series C Preferred Stock, and they shall have no voting rights and have liquidation preference. ~~During the year ended December 31, 2019, the Company had no Preferred C shares.~~

During the period ended December 31, 2020, the Company issued 150 Series C preferred shares and 10,000,000 warrants to two accredited investors for their financings for an aggregate value of $150,000.

During the period ended December 31, 2021, the Company issued 675 Series C preferred shares and 22,500,000 warrants to an accredited investor for their financings for an aggregate value of $675,000. The Series C preferred shares and warrants shall have a fixed conversion price equal to $0.004 per share of common stock, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock. The warrants are exercisable through May 2024. The Company considered the accounting effects of the existence of the conversion feature of the Series C Preferred Stock, and the issuance of warrants at the date of issuance. In accordance with the current accounting standards, the Company determined that it should account for the fair value of the conversion feature and relative fair value of the issued warrants (up to the face amount of the Series C Preferred Stock) as a deemed dividend of $675,000 and a charge to paid in capital.

During the period ended December 31, 2021, the two accredited investors converted 150 Series C preferred shares into 10,000,000 common shares at the conversion price of $0.01, leaving a balance of 675 Series C as of December 31, 2022, which with the reverse stock split leaves a balance of 6 as of December 31, 2023 and as of the period ending March 31, 2024.

Preferred Stock – Series D

~~During~~The ~~the~~Company ~~period~~is ~~ended~~authorized ~~December~~to ~~31,~~issue ~~2023, the Company authorized~~ 100,000 shares of preferred stock to be designated available for Series D preferred shares that have a convertible value into 100 shares of the Company’s common stock. The holder(s) of the shares of Series D Preferred Stock shall have no other rights, privileges or preferences with respect to the Series D Preferred Stock.

During the period ended December 31, 2023, the Company issued 15,000 Series D preferred shares and to an accredited investor for their $100,000 investment in the financing. The Series D preferred shares shall have a fixed conversion price equal to 100 ~~share’s~~shares of common stock, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock.

During the period ended March 31, 2024, the Company issued 60,000 Series D preferred shares and to an accredited investor for their $200,000 investment in the financing. The Series D preferred shares shall have a fixed conversion price equal to 100 ~~share’s~~shares of common stock, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock. The Company considered the accounting effects of the existence of the conversion feature of the Series D Preferred Stock at the date of issuance. As of the period ended ~~March~~June 3130, 2024, there is an 8 balance in the preferred D.

Common Stock

During the period ending ~~March~~June 3130, 2024, the Company issued 1,400,000 shares of its common stock to consultants for services valued at $47,024.

During the period ending ~~March~~June 3130, 2023, the Company issued 56,~~653~~231,~~671~~548 shares of its common stock, with a value of $62,315 to various noteholders and employees for conversions of their notes within the terms, resulting in no gain or loss on the transaction.

Common Stock Warrants

~~Since~~A ~~inception,~~summary ~~the Company has issued numerous warrants to purchase shares~~ of the Company’s ~~common~~warrant ~~stock~~activity ~~to shareholders, consultants~~ and ~~employees~~related asinformation ~~compensation~~is ~~for~~provided ~~services rendered.~~below:

A summary of the Company’s warrant activity and related information is provided below (the exercise price and the number of shares of common stock issuable upon the exercise of outstanding warrants have been adjusted to reflect a 1-for-75 reverse stock split.):

SCHEDULE OF WARRANT ACTIVITY

	Exercise Price $		Number of Warrants
Outstanding and exercisable at December 31, 2023		0.05 – 2.60		846,154
Warrants exercised		-		-
Warrants granted		-		-
Warrants expired		0.05-2.6		(~~217~~646,~~949~~154	)
Outstanding and exercisable at March 31, 2024		0.05 - 2.60		628,205
Outstanding and exercisable at June 30, 2024		0.05- 2.60		200,000

Stock Warrants as of March 31, 2024
Stock Warrants as of June 30, 2024
Exercise		Warrants		Remaining		Warrants
Price		Outstanding		Life (Years)		Exercisable
$	0.0515		~~300~~100,000		1.1562		~~300~~100,000
$	0.151625		100,000		10.8639		100,000
$	0.1625		100,000		0.64		100,000
$	2.60		128,205		0.01		128,205

During the period ended ~~March~~June 3130, 2024, the Company ~~had~~did nonot issue any warrants, with 646,154 of warrant ~~activity~~expiring, leaving a balance at June 30, 2024 of 200,000.

~~The~~During ~~outstanding~~the ~~and~~period ~~exercisable~~ended ~~warrants~~June at30, ~~March 31~~2023, ~~2024~~the ~~had~~Company issued 300,000 warrants to an ~~intrinsic~~investor ~~value~~as part of ~~approximately~~the ~~$20~~terms on their convertible note,~~103~~ and 157,692 of warrant expired, leaving a balance at June 30, 2023 of 746,154.

19The outstanding and exercisable warrants at June 30, 2024 had an intrinsic value of approximately $7,480.

Common Stock Options

Under the Company’s 2008 Equity Compensation Plan (the “2008 Plan”), we are authorized to grant stock options intended to qualify as Incentive Stock Options, “ISO”, under Section 422 of the Internal Revenue Code of 1986, as amended, non-qualified options, restricted and unrestricted stock awards and stock appreciation rights to purchase up to 7,000,000 shares of common stock to our employees, officers, directors and consultants, with the exception that ISOs may only be granted to employees of the Company and its subsidiaries, as defined in the 2008 Plan.

The 2008 Plan provides for the issuance of a maximum of 7,000,000 shares, of which, after adjusting for estimated pre-vesting forfeitures and expired options, approximately 2,235,000 were available for issuance as of ~~March~~June 3130, 2024.

No options were granted ~~during~~or outstanding as of the period ending ~~March~~June 3130, 2024.

1312. COMMITMENTS & CONTINGENCIES

Bonuses

The Company has an employment agreement with its CEO which, among other provisions, provide for the payment of a bonus, as determined by the Board of Directors, in amounts ranging from 15% to 50% of the executive’s yearly compensation, to be paid in cash or stock at the Company’s sole discretion, if the Company has an increase in year over year revenues and the Executive performs his duties (i) within the time frame budgeted for such duties and (ii) at or below the cost budgeted for such duties. No such bonuses were declared or accrued during the periods ending ~~March~~June 3130, 2024 or 2023.

Contingencies

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of ~~March~~June 3130, 2024, there was no pending or threatened litigation against the Company.

1413. SUBSEQUENT EVENTS

On ~~June 6~~July 29, 2024, ~~the~~we ~~Company~~issued ~~entered~~250,000 shares ~~into~~of acommon ~~convertible~~stock ~~note agreement~~ with a ~~third~~value ~~party~~of $6,000 to ~~whereby~~a ~~two~~consultant ~~previous~~for ~~notes~~services ~~totaling~~related ~~$60,000,~~to ~~where~~sales ~~paid~~for ~~off~~the ~~and~~GunAlert. ~~consolidated~~This ~~into~~agreement aallows ~~new~~for ~~$108~~the issuance of an additional 250,000 shares ~~note~~upon ~~with~~such atime ~~20%~~as ~~OID~~the ~~and~~consultant areaches ~~$0.03~~milestones ~~conversion~~related ~~rate~~to the agreement.

20On July 29, 2024, we issued 250,000 shares of common stock with a value of $6,000 to a consultant for services related to sales for the GunAlert.

On August 2, 2024, the Company entered into a Securities Purchase Agreement (“SPA”) for $300,000 with an investor. The SPA includes convertible promissory notes that will total $345,000 with an original issue discount of $45,000. The funds will be paid to the Company in one or more tranches, with the maturity date beginning at the end of each tranche and for a period of twenty-four months. The note has a conversion rate of $0.035 and an interest rate of $5%. The first tranche for $50,000 was received on August 6, 2024.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this report include forward-looking statements. These forward looking statements are based on our management’s current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “proposed,” “intended,” or “continue” or the negative of these terms or other comparable terminology. You should read statements that contain these words carefully, because they discuss our expectations about our future operating results or our future financial condition or state other “forward-looking” information. Many factors could cause our actual results to differ materially from those projected in these forward-looking statements, including but not limited to: variability of our revenues and financial performance; risks associated with product development and technological changes; the acceptance our products in the marketplace by existing and potential future customers; general economic conditions. You should be aware that the occurrence of any of the events described in this Quarterly Report could substantially harm our business, results of operations and financial condition, and that upon the occurrence of any of these events, the trading price of our securities could decline. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, growth rates, levels of activity, performance or achievements. We are under no duty to update any of the forward-looking statements after the date of this Quarterly Report to conform these statements to actual results.

Introduction

Unless otherwise noted, the terms “MetAlert, Inc.”, the “Company”, “we”, “us”, and “our” refer to the ongoing business operations of MetAlert, Inc. and our wholly -owned subsidiaries, Global Trek Xploration, and Level 2 Security Products, Inc.

Organization and Presentation

Overview

Headquartered in Los Angeles, ~~MLRT~~MetAlert has developed a suite of products and solutions, powered by a proprietary real time tracking technology platform, allowing remote monitoring, location-based tracking, ~~and~~ health data collection of humans, and theft recovery for high value assets. Many of the products have a wide range of applications, focusing on addressing two pressing global problems: remote patient ~~monitoring~~ ~~for people with cognitive decline and gun safety. Many of the products have a wide range of applications, focusing on addressing two pressing global problems: remote patient~~ monitoring for people with cognitive decline, and ~~gun~~the safety and recovery of firearms and other high value assets. Approximately 3% of the world’s population has ~~some~~a ~~sort~~form of cognitive impairment, such as Alzheimer’s, dementia, autism and traumatic brain injury. And there are over 400 million firearms just in the USUnited States alone,. ~~making~~Each ~~both~~represents ~~of these~~ sizeable markets which ~~MLRT~~Metalert has patent protected products and solutions for, that generate high margin recurring subscription service fees.

The Company was originally founded in 2002 as Global Trek Xploration, Inc. and, as part of a reverse merger, became publicly traded in 2008 as a 100% wholly owned subsidiary of GTX Corp, a Nevada corporation, under its former name “Deeas Resources Inc.” In September 2022, the public Company changed its name from GTX Corp to MetAlert, Inc. and effected a 1-for-65 reverse stock split of its issued and outstanding stock (OTC Pinks: MLRT). Post name change the Company kept its 2 wholly owned subsidiaries. During the periods covered by this report, MetAlert, Inc. and its subsidiaries were engaged in business operations that design, manufacture and sell various interrelated and complementary products and services in the wearable technology and Personal Location Services marketplace. In September of 2023, we acquired Level 2 Security, LLC and merged it into a new 100% wholly owned subsidiary Level 2 Security Products, Inc. During that period, the operations of LOCiMobile, Inc., another 100% wholly owned subsidiary, was consolidated under Global Trek Xploration and the corporate entity was dissolved. MetAlert now owns 100% of the issued and outstanding capital stock of its two operating subsidiaries - Global Trek Xploration, Inc. and Level 2 Security Products, Inc. The LOCiMOBILE digital assets are now under the management of the parent company MetAlert and remain there, post dissolution, of the corporate entity (LOCiMobile, Inc.). The Company’s digital platform which has been at the forefront of Smartphone application (“App”) development since 2008 designs mobile applications that turn the iPhone, iPad, Android and other GPS enabled handsets into a tracking device which can then be tracked from any mobile device or through our proprietary tracking portal or on any connected device with internet access.

Global Trek Xploration, Inc. is a wearable technology company which designs, manufactures, sells, and distributes tracking and remote patient monitoring solutions for humans. Utilizing patent protected proprietary hardware, software, connectivity, Global Positioning System (“GPS”) and Bluetooth Low Energy (“BLE”) monitoring and tracking platform, which provides real-time tracking and monitoring of people. Utilizing a miniature quad-band GPRS transceiver, antenna, circuitry, battery and inductive charging pad our solutions can be customized and integrated into numerous products whose location and movement can be monitored in real time over the Internet through our 24x7 tracking portal or on a web enabled cellular telephone. Our core products and services are supported by an IP portfolio of patents, patents pending, registered trademarks, copyrights, URL’s and a library of software source code, all of which is managed by Global Trek. Level 2 Security Products, Inc. is in the high value non-human asset monitoring and recovery business for items such as firearms, vehicles, bikes, boats, ATVs, and a host of other valuable mobile assets which require oversight monitoring and theft recovery.20

Global Trek Xploration, Inc. is a wearable technology company which designs, manufactures, sells, and distributes tracking and remote patient monitoring solutions for humans, by utilizing patent protected proprietary hardware, software, connectivity, Global Positioning System (“GPS”) and Bluetooth Low Energy (“BLE”) monitoring and tracking platform, which provides real-time tracking and monitoring of people. Utilizing a miniature quad-band GPRS transceiver, antenna, circuitry, battery and inductive charging pad our solutions can be customized and integrated into numerous products whose location and movement can be monitored in real time over the Internet through our 24x7 tracking portal or on a web enabled cellular telephone. Our core products and services are supported by an IP portfolio of patents, patents pending, registered trademarks, copyrights, URL’s and a library of software source code, all of which is managed by Global Trek. Level 2 Security Products, Inc. is in the high value non-human asset monitoring and recovery business for items such as firearms, vehicles, bikes, boats, ATVs, and a host of other valuable mobile assets which require oversight monitoring and theft recovery.

Other technology that the Company has developed or resells includes health and safety monitoring products and wellness products that are complementary to our main product lines and general mission.

Operations

The Company designs, develops, manufactures, sells, and distributes health and safety monitoring products and services, along with other related medical supplies and equipment, and asset theft and recovery products and services, all through a global business to business (“B2B”) and business to consumer (“B2C”) network of resellers, affiliates, distributors, nonprofit organizations, local, state, and federal government agencies, police departments, manufacturers reps, retailers and direct to consumer. Offering a variety of electronic and non-electronic devices and equipment, a proprietary Internet of things (“IoT”) enterprise monitoring platform and a licensing subscription business model. The Company provides a complete end to end solution of hardware, middleware, apps, connectivity, licensing, and professional services, letting our customers know where or how someone, or something, is at the touch of a button, delivering safety, security, and peace of mind in real-time. Except for our military products and recently acquired Level 2 Security devices, all of our consumer and enterprise tracking products funnel into the MetAlert IoT monitoring platform which supports end user customers in over 35 countries. The Company is also in the business of licensing intellectual property, monetizing its patent portfolio, and providing backend infrastructure logistic and subscription management services.

Results of Operations

The following discussion should be read in conjunction with our interim consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report.

~~Three Months Ended March 31, 2024 (“Q1 20243”) Compared to the Three Months Ended March 31, 2023 (“Q1 2023”)~~21

	Three Months Ended March 31,
	2024						2023
	$			% of Revenues			$			% of Revenues
Product sales		24,942			50	%		54,391			75	%
Service income		23,376			48	%		18,302			25	%
IP royalties		-			0	%		-			0	%
Total revenues		48,318			100	%		72,693			100	%
Cost of products sold		4,474			10	%		26,063			36	%
Cost of service revenue		655			1	%		4,305			6	%
Cost of licensing revenue		-			0	%		-			0	%
Cost of goods sold		5,129			11	%		30,368			42	%
Gross profit		43,189			89	%		42,325			58	%
Operating expenses:
Wages and benefits		82,883			172	%		123,645			170	%
Professional fees		56,282			116	%		31,524			43	%
Sales and marketing expenses		7,785			16	%		-			0	%
General and administrative		72,246			150	%		65,869			91	%
Total operating expenses		219,196			4542	%		221,038			304	%
Gain (loss) from operations		(176,007	)		-364	%		(176,712	)		-246	%
Other income (expense), net		(75,138	)		-156	%		(70,433	)		-97	%
Net income (loss)		(251,145	)		-520	%		(249,146	)		-343	%

Three Months Ended June 30, 2024 (“Q2 2024”) Compared to the Three Months Ended June 30, 2023 (“Q2 2023”)

	Three Months Ended June 30,
	2024						2023
	$			% of Revenues			$			% of Revenues

Product sales		16,607			39	%		36,232			74	%
Service income		27,556			61	%		12,607			26	%
Total revenues		44,163			100	%		48,839			100	%
Cost of products sold		11,851			26	%		40,719			83	%
Cost of service revenue		3,082			7	%		2,594			5	%
Cost of goods sold		14,933			33	%		43,313			89	%
Gross profit		29,230			67	%		5,526			11	%

Operating expenses:
Wages and benefits		48,918			109	%		118,849			243	%
Professional fees		11,138			25	%		20,399			42	%
Sales and marketing expenses		3,075			7	%		-			0	%
General and administrative		53,693			120	%		47,569			97	%
Total operating expenses		116,824			260	%		186,817			383	%

Gain (loss) from operations		(87,593	)		-194	%		(181,291	)		-371	%

Other income (expense)-, net		(66,264	)		-194	%		(27,293	)		-56	%
Net income (loss)		(153,858	)		-342	%		(208,584	)		-427	%

Revenues

Revenues were $4844,~~318~~163 for the three months ended ~~March~~June 3130, 2024 compared to $7248,~~693~~839 for the three months ended ~~March~~June 3130, 2023, representing a decrease of 3410%., This decrease was primarily driven from transitioning out of direct-to-consumer PPE sales into our core B2B business and the effort to get the new Level 2 Security Products out to market.

As a result, during the ~~first~~second quarter of ended ~~March 31~~June 30, 2024, we did not meet our overall revenue goals~~, and we had a significant setback due to delays in getting our 10K filed~~. We did however see some positive trends compared to Q1Q2 2023, with international subscriptions increasing by 9922% ~~and~~for ~~domestic~~the ~~subscriptions~~period byended ~~146%~~Q2 2024 as compared to Q2 2023. SmartSole ~~B2C~~ B2B sales increasing by ~~124~~33% in Q1Q2 of 2024, compared to Q1Q2 of 2023. Unlike B2C sales, where subscriptions activate immediately after purchase, the B2B sales ~~has~~typically have a lag of between 2-4 months, allowing for the distributor to receive the inventory and then activate the customers unit as they sell into the marketplace. Thus, the increase in B2B subscriptions without the corresponding revenue increase, until the distributor inventories are depleted and replenished. Thus, we are seeing increased recurring revenues as these distributor product sales are turned on and activated, with a 119% increase from Q2 2024 as compared to Q2 2023.

This came as a direct result to some improvements in our production capacity, and we were able to streamline some manufacturing processes, thereby increasing our production quantities and enhancing our low inventory position. We were also able to leverage our OEM manufacturing in Germany. Overall, we still have some supply chain issues, but we are starting to see noticeable improvements in lead times, increases in inventory and shortening our time from order to delivery by 2-3 weeks on average. As we discussed last quarter, we are still evaluating ways to scale up production in the U.S., Germany and we are starting to look at Mexico to reduce costs by 10% to 18% and increase production capacity by 50%.

We also worked on expanding our SmartSole distribution and began pilot programs in ~~the~~Spain ~~Netherlands~~and Portugal and with a large security company in Mexico City bywhose ~~commencing a~~ testing and evaluation period has been successfully completed and we have entered into negotiations and planning of a commercial rollout.

Late last year we took transformative steps to broaden our product line and add new markets in order to increase our product and subscription revenues. We successfully acquired Level 2 Security LLC, which we merged into our new 100% wholly owned subsidiary Level 2 Security Products, Inc. During Q1Q2 ~~2024,~~ we ~~brought~~continue ~~in a few marketing consultants and retired policy officers~~ to ~~help~~explore ~~us build a go to market strategy for the GunAlert product. During that time, we discovered there are~~ numerous avenues and channel partners for us to engage with, of which we ~~have~~continue ~~begun~~ a concerted outreach campaign. ~~We also made some significant improvements to the device and filed additional IP.~~

In summary, we made several positive steps forward but did not meet our revenue targets yet exceed the gross margin for the same quarter in 2023.

During the period ended ~~March~~June 3130, 2024, the Company’s customer base and revenue streams were comprised of approximately 5651.2628% B2B (Wholesale Distributors and Enterprise Institutions), 4348.7472% B2C (consumers and government agencies who bought on the behalf of consumers, through our online ecommerce platform and through Amazon, Google and iTunes), 0% IP (our monetization campaign from consulting, licensing and asserting our patents) and 0% Military and Law Enforcement.

During the period ended ~~March~~June 3130, 2023, the Company’s customer base and revenue streams were comprised of approximately 7874.4319% B2B (Wholesale Distributors and Enterprise Institutions), 2125.5781% B2C (consumers and government agencies who bought on the behalf of consumers, through our online ecommerce platform and through Amazon, Google and iTunes), 0% IP (our monetization campaign from consulting, licensing and asserting our patents) and 0% Military and Law Enforcement.

Cost of goods sold

Cost of goods sold were $514,~~128~~933 for the three months ended ~~March~~June 3130, 2024 compared to $3043,~~368~~312 for the three months ended ~~March~~June 3130, 2023, representing a decrease of 8366%. ~~This~~The decrease was primarily due to ~~the~~a lower ~~distributor~~number ~~hardware sales, which are larger volume orders, that are dependent upon the activation~~ of ~~SmartSoles~~distributor ~~sold into their respective markets, which affects the timeliness of their~~ hardware ~~orders to maintain adequate inventory levels~~sales.

We expect our margins to increase once we start ramping up our subscriptions and licensing and sell more of our proprietary products like our SmartSoles and GunAlert, where we have limited no competition. Our overall gross margin was higher than in 2023, predominately because most of our revenues were subscription based with little corresponding expense.

We continue to work with all our suppliers to reduce unnecessary expenses related to production inefficiencies in order to position ourselves to maximize profits as we scale back up.

Wages and benefits

Wages and benefits decreased ~~by 33~~59% orin ~~$40,761 for~~ the three months ended ~~March~~June 3130, 2024 as compared to three months ended ~~March~~June 3130, 2023, ~~because~~predominantly because of cost cutting and time saving initiatives.

Professional fees

Professional fees consist of costs attributable to consultants and contractors who primarily spend their time on legal, accounting, product development, business development, corporate advisory services and shareholder communications. Such costs ~~increased~~decreased $249,~~758~~261 or 7945% in the three months ended ~~March~~June 3130, 2024 as compared to in the three months ended ~~March~~June 3130, 2023. Even though some professional fees have decreased as more responsibilities were transferred from outside contractors and consultants to in-house personnel, fees related to investor relations and business development have increased due to new products lines and the impending release of the company’s updated SmartSole products on new GunAlert product line, and ~~overaged~~overages in our 10K audit fees.

Sales and marketing expenses

Sales and marketing expenses increased by 100% or $73,~~805~~075 in three months ended ~~March~~June 3130, 2024 in comparison to the three months ended ~~March 31,~~June 30, 2023. The increase was primarily due to the release of the new GunAlert product line as we build brand awareness across multiple media platforms.

General and administrative

General and administrative costs in three months ended June 30, 2024 increased by $6,123 or 13% in comparison to the three months ended June 30, 2023, mostly due to increases in amortization expense of IP. While at the same time, the Company continues many cost saving measures, including the entire senior management team deferring salaries.

Other income/(expense), net

Other expenses, net increased 143% or $38,970 in the three months ended June 30, 2024 compared to the three months ended June 30, 2023. This increase was primarily as a result of the increases in interest expense, the amortization of debt discounts related to the Level 2 acquisition.

Net income/(loss)

Net loss decreased by 26% or $54,726 from Q2 2024 in comparison to Q2 2023. This increase, though small was primarily due to the lower revenues as we transition out of direct-to-consumer PPE sales into our core B2B business and the effort to get the new Level 2 Security Products out to market.

Six Months Ended June 30, 2024 (“Q1 and Q2 2024”) Compared to the Six Months Ended June 30, 2023 (“Q1 and Q2 2023”)

	Six Months Ended June 30,
	2024						2023
	$			% of Revenues			$			% of Revenues

Product sales		41,549			45	%		90,623			75	%
Service income		50,932			55	%		30,909			25	%
Total revenues		92,481			100	%		121,532			100	%
Cost of products sold		16,326			18	%		66,781			55	%
Cost of service revenue		3,737			4	%		6,899			6	%
Cost of goods sold		20,063			22	%		73,680			61	%
Gross profit		72,418			78	%		47,852			39	%

Operating expenses:
Wages and benefits		131,801			143	%		242,494			200	%
Professional fees		67,420			73	%		51,923			43	%
Sales and marketing expenses		10,859			12	%		(20	)		0	%
General and administrative		125,939			136	%		113,458			93	%
Total operating expenses		336,019			356	%		407,855			336	%

Gain (loss) from operations		(263,601	)		-278	%		(360,003	)		-296	%

Other income (expense), net		(141,401	)		-153	%		(97,727	)		-80	%
Net income (loss)		(405,002	)		-431	%		(457,730	)		-377	%

Revenues

Revenues as a whole in Q1 and Q2 2024 decreased by 24% or $29,050 in comparison to Q1 and Q2 2023. This decrease was primarily driven from transitioning out of direct-to-consumer PPE sales into our core B2B business and the effort to get the new Level 2 Security Products out to market.

As a result, during the Q1 & Q2 quarters ended June 30, 2024, we did not meet our overall revenue goals. We did however see some positive trends compared to Q1 & Q2 2023, with international subscriptions increasing by 67% for the period ended Q2 2024 as compared to Q2 2023. SmartSole B2B sales increasing by 124% in Q1 & Q2 of 2024, compared to Q1 & Q2 of 2023. Unlike B2C sales, where subscriptions activate immediately after purchase, the B2B sales typically have a lag of between 2-4 months, allowing for the distributor to receive the inventory and then activate the customers unit as they sell into the marketplace. Thus, the increase in B2B subscriptions without the corresponding revenue increase, until the distributor inventories are depleted and replenished. Thus, we are seeing increased recurring revenues as these distributor product sales are turned on and activated, with a 65% increase from Q1 2024 as compared to Q2 2023.

We also worked on expanding our SmartSole distribution and began pilot programs in the Netherlands, Spain and Portugal and with a large security company in Mexico City whose testing and evaluation period having been successfully completed and we have entered into negotiations and planning for a commercial rollout.

Late last year we took transformative steps to broaden our product line and add new markets in order to increase our product and subscription revenues. We successfully acquired Level 2 Security LLC, which we merged into our new 100% wholly owned subsidiary Level 2 Security Products, Inc. During Q1 & Q2 2024, we brought in a few marketing consultants and retired policy officers to help us build a go to market strategy for the GunAlert product. During that time, we discovered there are numerous avenues and channel partners for us to engage with, of which we have begun a concerted outreach campaign. We also made some significant improvements to the device and filed additional IP.

In summary, we made several positive steps forward but did not meet our revenue targets yet exceed the gross margin for the same period in 2023.

During the period ended June 30, 2024, the Company’s customer base and revenue streams were comprised of approximately 56.26% B2B (Wholesale Distributors and Enterprise Institutions), 43.74% B2C (consumers and government agencies who bought on the behalf of consumers, through our online ecommerce platform and through Amazon, Google and iTunes), 0% IP (our monetization campaign from consulting, licensing and asserting our patents) and 0% Military and Law Enforcement.

During the period ended June 30, 2023, the Company’s customer base and revenue streams were comprised of approximately 78.43% B2B (Wholesale Distributors and Enterprise Institutions), 21.57% B2C (consumers and government agencies who bought on the behalf of consumers, through our online ecommerce platform and through Amazon, Google and iTunes), 0% IP (our monetization campaign from consulting, licensing and asserting our patents) and 0% Military and Law Enforcement.

Cost of goods sold

Cost of goods sold decreased by 73% or $56,618 during Q1 and Q2 2024 in comparison to Q1 and Q2 2023. This decrease was primarily due to the lower distributor hardware sales, which are larger volume orders, that are dependent upon the activation of SmartSoles sold into their respective markets, which affects the timeliness of their hardware orders to maintain adequate inventory levels.

We expect our margins to increase once we start ramping up our subscriptions and licensing and sell more of our proprietary products like our SmartSoles and GunAlert, where we have no competition. Our overall gross margin was higher than in 2023, predominately because most of our revenues were subscription based with little corresponding expense.

We continue to work with all our suppliers to reduce unnecessary expenses related to production inefficiencies in order to position ourselves to maximize profits as we scale back up.

Wages and benefits

Wages and benefits during Q1 and Q2 2024 decreased by 46% or $110,693 in comparison to Q1 and Q2 2023, because of cost cutting and time saving initiatives.

Professional fees

Professional fees consist of costs attributable to consultants and contractors who primarily spend their time on legal, accounting, product development, business development, corporate advisory services and investor relations. Such costs increased $15,498 or 30% during Q1 and Q2 2024 as compared to Q1 and Q2 2023. Even though some professional fees have decreased as more responsibilities were transferred from outside contractors and consultants to in-house personnel, fees related to investor relations and business development have increased due to new products lines and the impending release of the company’s updated SmartSole products on new GunAlert product line, and overages in our 10K audit fees.

Sales and marketing expenses

Sales and marketing expenses decreased by 100% or $10,880 during Q1 and Q2 2024 in comparison to Q1 and Q2 2023. The increase was primarily due to the release of the new GunAlert product line as we build brand awareness across multiple media platforms.

General and administrative

General and administrative costs induring ~~three~~Q1 ~~months~~and ~~ended~~Q2 ~~March 31,~~ 2024 increased by $712,~~389~~480 or 11% in comparison to ~~the~~Q1 ~~three~~and ~~months~~Q2 ~~ended March 31,~~ 2023, mostly due to increases in ~~investor~~amortization ~~relations~~ expense of IP. While at the same time, the Company continues many cost saving measures, including the entire senior management team deferring salaries.

Other income /(expense), net

Other expense, net increased 745% or $442,~~704~~675 infrom ~~the~~Q1 ~~three~~and ~~months~~Q2 ~~ended March 31,~~ 2024 ~~compared~~ to ~~the~~Q1 ~~three~~and ~~months~~Q2 ~~ended March 31,~~ 2023. This increase was primarily as a result of the ~~gain~~increases in interest expense, the amortization of debt discounts ~~and~~related ~~financing~~to ~~costs~~the Level 2 acquisition.

~~Net income (loss)~~24

Net income/(loss increased by 1% or $2,000 from in the three months ended March 31, 2024 compared to the three months ended March 31, 2023. This increase, though small was primarily due to the lower revenues as we transition out of direct-to-consumer PPE sales into our core B2B business and the effort to get the new Level 2 Security Products out to market.)

Net loss decreased by 12% or $52,728 from Q1 and Q2 2024 to Q1 and Q2 2023. This decrease, was primarily due to higher net profits as we transition out of direct-to-consumer PPE sales into our core B2B business and the effort to get the new Level 2 Security Products out to market, coupled with the cost savings form executive salaries as the Company works to maintain its cost cutting initiatives.

Liquidity and Capital Resources

As of ~~March~~June 3130, 2024, we had $8629,~~095~~576 of cash and cash equivalents, and a working capital deficit of $4,~~035~~168,~~819~~975, compared to $6845,~~440~~089 of cash and cash equivalents and a working capital deficit of $43,~~049~~614,~~388~~467 as of December 31, 2023.

During the ~~three~~six months ended ~~March~~June 3130, 2024, our net loss was $~~251~~405,~~145~~002 compared to a net loss of $~~249~~457,~~146~~730 for the ~~three~~six months ended ~~March 31~~June 30, 2023. Net cash used in operating activities in the ~~three~~six months ended ~~March~~June 3130, 2024 and in the ~~three~~six months ended ~~March~~June 3130, 2023 was $~~160~~252,~~439~~915 and $49155,~~301~~814, respectively.

Net cash used in investing activities during the ~~three~~six months ended ~~March~~June 3130, 2024 and ~~March~~June 3130, 2023 was $3,000 and $0, respectively.

Net cash provided by financing activities during the ~~three~~six months ended ~~March~~June 3130, 2024 was $~~181~~217,~~094~~051 and consisted of $~~200~~40,000 received for the issuance of debt, $200,000 received for the issuance of preferred shares, and payments to the line of credit of $38,~~976~~019 and payments on debt of $14,930. Net cash provided by financing activities during the ~~three~~six months ended ~~March~~June 3130, 2023 was $45192,~~437~~368 and consisted of $65190,000 received for the issuance of debt, $746,~~000~~881 from the use of the line of credit, and payments to the line of credit of $2627,~~563.~~791 ~~This~~and ~~represents~~payments on andebt ~~increase~~ of ~~298% in cash provided by financing activities~~$16,722.

Because revenues from our operations have, to date, been insufficient to fund our working capital needs, we currently rely on the cash we receive from our financing activities to fund our growth, capital expenditures and to support our working capital requirements. The sale of our products and services is expected to enhance our liquidity in 2024, although the amount of revenues we receive in 2024 still cannot be estimated.

Until such time as our products and services can support our working capital requirement, we expect to continue to generate revenues from our other licenses, subscriptions, international distributors, hardware sales, professional services and new customers in the pipeline. However, the amount of such revenues is unknown and is not expected to be sufficient to fund our working capital needs. For our internal budgeting purposes, we have assumed that such revenues will not be sufficient to fund all of our planned operating and other expenditures during 2024. In addition, our actual cash expenditures may exceed our planned expenditures, particularly if we invest in the development of improved versions of our existing products and technologies, and if we increase our marketing expenses. Accordingly, we anticipate that we will have to continue to raise additional capital in order to fund our operations in 2024. No assurance can be given that we will be able to obtain the additional funding we need to continue our operations.

In order to continue funding our growth, IP, ~~and~~ working capital needs, asand ~~well as our~~ new product development costs, during the first ~~quarter~~six months of 2024, we continued to draw down on our credit line to fund purchase orders. However, no assurance can be given that the investor will provide the funding, if and when requested by us.

Going Concern

The consolidated financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has stockholders’ deficit of $34,~~902~~056,~~995~~852 and negative working capital of $4,~~035~~168,~~818~~974 as of ~~March~~June 3130, 2024 and used cash in operations of $~~160~~252,~~439~~915 during the current period then ended. A significant part of our negative working capital position at ~~March~~June 3130, 2024 consisted of $1,~~720~~758,~~259~~215, of amounts ~~due~~ due to various accredited investors of the Company for convertible promissory notes, loans and a letter of credit, net of discount. The ~~Company~~ Company anticipates further losses in the development of its business. Please see the section entitled “Risk Factors” included in in our Annual Report on Form 10-K for the year ended December 31, 2023 for more information regarding risks associated with our business.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Inflation

We ~~do not~~ believe that our business and operations ~~have~~could ~~been~~be materially affected by inflation., as unexpected increases in our costs could affect how we manage operations

Critical Accounting Policies and Estimates

There are no material changes to the critical accounting policies and estimates described in the section entitled “Critical Accounting Policies and Estimates” under Item 7 in our Annual Report on Form 10-K for the year ended December 31, 2023.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company”, we are not required to provide the information under this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Based on the evaluation as of ~~March~~June 3130, 2024, ~~for the reasons set forth below,~~ our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

ITEM 2.(a). UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

~~On January 10, 2024, we issued 600,000 shares of common stock with a value of $19,740 to a consultant for services~~None.

On February 1, 2024, we issued 800,000 shares of common stock with a value of $27,144 to a consultant for services.

The issuance of the above shares was exempt from registration pursuant to Section 4(2) of the Securities Act of 1933, as amended, in reliance on the exemptions provided by Regulation D and Section 4(a)(2), as applicable under the Securities Act.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

(a) Exhibits

31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act

31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act

32.1		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act

32.2		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act

101.INS		Inline XBRL Instance Document

101.SCH		Inline XBRL Taxonomy Extension Schema

101.CAL		Inline XBRL Taxonomy Extension Calculation

101.DEF		Inline XBRL Taxonomy Extension Definition

101.LAB		Inline XBRL Taxonomy Extension Label

101.PRE		Inline XBRL Taxonomy Extension Presentation

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	METALERT, INC.
Date: June 26, 2024	By:	/s/ ALEX MCKEAN
Date: August 19, 2024	By:	/s/ ALEX MCKEAN
		Alex McKean,
		Chief Financial Officer (Principal Financial Officer)
Date: August 19, 2024	By:	/s/ PATRICK BERTAGNA
		Patrick Bertagna,
		Chief Executive Officer

Date: June 26, 2024	By:	/s/ PATRICK BERTAGNA
		Patrick Bertagna,
		Chief Executive Officer

Filing Compare · Metalert, Inc.